<!DOCTYPE html>
<html>
    <head>
        <title>ONALABS QMS : OV ONAVITAL Medical Device File Checklist</title>
        <link rel="stylesheet" href="styles/site.css" type="text/css" />
        <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    </head>

    <body class="theme-default aui-theme-default">
        <div id="page">
            <div id="main" class="aui-page-panel">
                <div id="main-header">
                    <div id="breadcrumb-section">
                        <ol id="breadcrumbs">
                            <li class="first">
                                <span><a href="index.html">ONALABS QMS</a></span>
                            </li>
                                                    <li>
                                <span><a href="OV-ONAVITAL-MDR-Product-Technical-File_3342337.html">OV ONAVITAL MDR Product Technical File</a></span>
                            </li>
                                                </ol>
                    </div>
                    <h1 id="title-heading" class="pagetitle">
                                                <span id="title-text">
                            ONALABS QMS : OV ONAVITAL Medical Device File Checklist
                        </span>
                    </h1>
                </div>

                <div id="content" class="view">
                    <div class="page-metadata">
                            
        
    
        
    
        
        
            Created by <span class='author'> Richard Bunney</span>, last modified by <span class='editor'> Jaime Punter</span> on Jun 16, 2025
                        </div>
                    <div id="main-content" class="wiki-content group">
                    <p><span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">COMPANY CONFIDENTIAL</span>  <span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">UNCONTROLLED IF PRINTED</span> </p><p>Owner: Elisabet del Valle Alvaro, CEO and Founder</p><p>PLEASE DO NOT EDIT THIS PAGE AS INFORMATION IS AUTOMATICALLY UPDATED</p><ul><li><p><a class="external-link" href="https://tinnisoothe.atlassian.net/wiki/spaces/TF/pages/3833857/Device+Version+History#1.-Purpose" rel="nofollow">1. Purpose</a></p></li><li><p><a class="external-link" href="https://tinnisoothe.atlassian.net/wiki/spaces/TF/pages/3833857/Device+Version+History#2.-Version-History" rel="nofollow">2. Version History</a></p></li><li><p><a class="external-link" href="https://tinnisoothe.atlassian.net/wiki/spaces/TF/pages/3833857/Device+Version+History#3.-Document-Distribution" rel="nofollow">3. Document Distribution</a></p></li></ul><h3 id="OVONAVITALMedicalDeviceFileChecklist-1.Purpose">1. Purpose</h3><p>To confirm the completeness of the medical device file. </p><p>The European Union Medical Device Regulation (EU MDR) 2017/745 outlines specific requirements for technical documentation, particularly in Annexes II and III.</p><p>Annex II of the EU MDR specifies the necessary elements of technical documentation:</p><ol start="1"><li><p><strong>Device Description and Specification</strong>: Includes intended purpose, intended users, and device variants.</p></li><li><p><strong>Information to be Supplied by the Manufacturer</strong>: Labels and instructions for use.</p></li><li><p><strong>Design and Manufacturing Information</strong>: Design stages, manufacturing processes, and quality control measures.</p></li><li><p><strong>General Safety and Performance Requirements (GSPR)</strong>: Evidence demonstrating compliance with applicable requirements.</p></li><li><p><strong>Benefit-Risk Analysis and Risk Management</strong>: Risk management plans and reports.</p></li><li><p><strong>Product Verification and Validation</strong>: Pre-clinical and clinical data supporting device performance.</p></li></ol><p>Annex III focuses on post-market surveillance, requiring:</p><ul><li><p><strong>Post-Market Surveillance Plan</strong></p></li><li><p><strong>Periodic Safety Update Reports (PSUR)</strong></p></li><li><p><strong>Post-Market Clinical Follow-up (PMCF) Plan and Reports</strong></p></li></ul><p>For SaMD, additional considerations include software lifecycle processes, cybersecurity, and usability.</p><h3 id="OVONAVITALMedicalDeviceFileChecklist-2.InformationtobeprovidedintheMedicalDeviceFile">2. Information to be provided in the Medical Device File</h3><div class="table-wrap"><table data-table-width="1800" data-layout="full-width" data-local-id="67ba7e97-c4b0-4d32-ae71-d58515011133" class="confluenceTable"><colgroup><col style="width: 386.0px;"/><col style="width: 378.0px;"/><col style="width: 378.0px;"/><col style="width: 378.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Parts</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Regulation</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Cross-reference to ONALABS Completeness Check Form</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td class="confluenceTd"><p>Part A – Device Description and Specifications including Variants and Accessories</p></td><td class="confluenceTd"><p>Annex II Section 1</p></td><td class="confluenceTd"><p>Section 4.2 Part 1</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="1"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="2"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part B – Information to be supplied by the Manufacturer</p></td><td class="confluenceTd"><p>Annex II Section 2</p></td><td class="confluenceTd"><p>Section 4.2 Part 2</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="3"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="4"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part C – Design and Manufacturing Information</p></td><td class="confluenceTd"><p>Annex II Section 3</p></td><td class="confluenceTd"><p>Section 4.2 Part 3</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="5"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="6"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part D – General Safety and Performance Requirements</p></td><td class="confluenceTd"><p>Annex II Section 4</p></td><td class="confluenceTd"><p>Section 4.2 Part 4</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="7"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="8"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part E – Benefit-Risk Analysis and Risk Management</p></td><td class="confluenceTd"><p>Annex II Section 5</p></td><td class="confluenceTd"><p>Section 4.2 Part 5</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="9"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="10"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part F – Pre-clinical Information</p><p>(If this section contains substantial amount of information, it is recommended to break it down into logical smaller sub- sections)</p></td><td class="confluenceTd"><p>Annex II Sections 6.1.a, 6.1.b, 6.2.d, 6.2.f</p></td><td class="confluenceTd"><p>Section 4.2 Parts 6.1-6.5; 6.11, 6.12, 6.15-6.17</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="11"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="12"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>6.11, 6.13, 6.14 and 6.17 are not applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>Part G – Clinical Evaluation, PMS and PMCF</p></td><td class="confluenceTd"><p>Annex II Section 6.1.c, 6.1.d; Annex III</p></td><td class="confluenceTd"><p>Section 4.2 Parts 6.6, 6.7</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="13"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="14"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part H – Information related to</p><ul><li><p>Medicinal Substances incorporated in the device</p></li><li><p>Animal/Human tissue derivatives or cells or other non-viable biological substances</p></li><li><p>Substances absorbed by or locally dispersed in the human body (for Rule 21 devices)</p></li></ul></td><td class="confluenceTd"><p>Annex II Section 6.2.a – 6.2.c</p></td><td class="confluenceTd"><p>Section 4.2 Parts 6.8-6.10</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="15"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="16"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>not applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>Part I - Sterilisation and Information related to re-usable surgical instruments</p></td><td class="confluenceTd"><p>Annex II Section 6.2.e</p></td><td class="confluenceTd"><p>Section 4.2 Parts 6.13, 6.14</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="17"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="18"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>not applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>Part J – Declaration of Conformity</p></td><td class="confluenceTd"><p>Annex IV</p></td><td class="confluenceTd"><p>Section 4.2 Part 6.18</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="19"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="20"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>Part K - Specific information for Class III implantable devices, and Class IIb active devices intended to administer or remove medicinal substances as per Rule 12 to determine the need for CECP process</p></td><td class="confluenceTd"><p>MDCG 2019-3</p></td><td class="confluenceTd"><p>Section 5</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="21"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="22"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>not applicable</strong></p></td></tr></tbody></table></div><h3 id="OVONAVITALMedicalDeviceFileChecklist-3.CompletenessCheck">3. Completeness Check</h3><p><strong>Part A: Device Description and Specifications</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="da5456ca-fb23-456d-802c-d8677f572bde" class="confluenceTable"><colgroup><col style="width: 340.0px;"/><col style="width: 271.0px;"/><col style="width: 486.0px;"/><col style="width: 474.0px;"/><col style="width: 221.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="1"><li><p><span class="legacy-color-text-inverse">Device Description and Specifications Including Variants and Accessories</span></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">1.1 Device Description</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.1.1 General description including product or trade names, principles of operation, mode of action</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The device description should enable understanding of the design, packaging, sterilisation, or other characteristics of the device.</p><p>Sufficient information should be provided to distinguish different variants of the device, and the intended purpose of different design features. For example, if one variant of a device has a coating and another does not, what is the intended purpose of that coating, and why are both variants considered to meet the requirements for safety and performance?</p><p>Pictures and schematics should be provided wherever possible to enable an understanding of the device design features and intended purpose.</p></td><td class="confluenceTd"><p><a href="OV-A1.1.-Device-Description_3342412.html" data-linked-resource-id="3342412" data-linked-resource-version="44" data-linked-resource-type="page">OV A1.1. Device Description</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="23"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="24"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.1.2 Accessories included</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The following information should be provided for any accessories (including Class I) associated with the device:</p><p>·     Brief description of the accessory/accessories and how they are used with the device(s);</p><p>·     Classification of the accessories and rationale for classification;</p><p>·     Technical Documentation references (file name, issue status, date).</p><p>Indicate clearly if the accessories are packaged with the device or provided separately or both. Also clarify if the accessories are already certified and if yes, provide the certificate references.</p><p>Evidence should also be provided within the Technical Documentation to demonstrate compatibility of the devices with any applicable accessories.</p></td><td class="confluenceTd"><p><a href="OV-A.1.2.-Intended-Use-Statement_3342423.html" data-linked-resource-id="3342423" data-linked-resource-version="37" data-linked-resource-type="page">OV A.1.2. Intended Use Statement</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="25"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="26"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.1.3 Accessories not included but necessary for use</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The Technical Documentation should identify any accessories which are not included with the device, but which are necessary for its use.</p></td><td class="confluenceTd"><p> <a href="OV-A.1.2.-Intended-Use-Statement_3342423.html" data-linked-resource-id="3342423" data-linked-resource-version="37" data-linked-resource-type="page">OV A.1.2. Intended Use Statement</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="27"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="28"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">1.2 Intended Purpose and Intended Users</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.2.1 Intended purpose including any clinical claims</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The intended purpose or intended use should provide enough detail to explain the disease conditions the device is intended to treat or monitor, the basic principles of operation (i.e. intended users and environment), the intended patient population and the indications and contraindications of the device.</p><p>·     Indications and contraindications should be supported by objective evidence (e.g., evidence provided in the risk assessment and clinical evaluation reports).</p><p>·     The intended use must include use of the device as a “medical device” as defined by MDR Article 2 unless the device is a product without a medical purpose as listed in MDR Annex XVI.</p><p>·     Ensure the intended use been described consistently throughout the file (e.g. in the IFU, risk management documentation, clinical evaluation report, and design requirements).</p><p>·     For clarity this should be separate from the device description.</p></td><td class="confluenceTd"><p> <a href="OV-A.1.2.-Intended-Use-Statement_3342423.html" data-linked-resource-id="3342423" data-linked-resource-version="37" data-linked-resource-type="page">OV A.1.2. Intended Use Statement</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="29"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="30"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.2.2 Intended users</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>Identify the intended users of the device (i.e. medical professionals in a specialty, clinical nurses, lay persons).</p></td><td class="confluenceTd"><p> <a href="OV-A.1.2.-Intended-Use-Statement_3342423.html" data-linked-resource-id="3342423" data-linked-resource-version="37" data-linked-resource-type="page">OV A.1.2. Intended Use Statement</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="31"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="32"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">1.3 Basic UDI-DI &amp; EMDN code</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.3.1 Basic UDI-DI and any other relevant UDI related information</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The Basic UDI-DI assigned by the manufacturer should be provided. Additional guidance on Basic UDI-DI may be found in the MDCG documents published on the EU Commission website.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/4b5b2942-aaab-4b78-a188-df111a8d903e_en?filename=md_mdcg_2018_5_software_en.pdf" rel="nofollow">MDCG 2018-5 UDI Assignment to Medical Device Software</a></p></td><td class="confluenceTd"><p><a href="OV-A1.3.-General-Administrative-Information_3342439.html" data-linked-resource-id="3342439" data-linked-resource-version="24" data-linked-resource-type="page">OV A1.3. General Administrative Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="33"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="34"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.3.2 EMDN code (previously referred to as CND code)</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>European Medical Device Nomenclature code (EMDN code; previously referred to as CND code) should be identified (not mandatory for Class III and IIb implantable non-WET devices).</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/de470384-e8be-45e7-a334-226757f8816d_en?filename=mdcg_2024-2_en.pdf" rel="nofollow">MDCG 2024-2 Procedures for the update of EMDN</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/d90b3f63-1d62-43e6-bf5f-fb32ea7c47a2_en?filename=md_2021-12_en.pdf" rel="nofollow">MDCG 2021-12 FAQ on the European Medical Device Nomenclature (EMDN)</a></p></td><td class="confluenceTd"><p><a href="OV-A1.3.-General-Administrative-Information_3342439.html" data-linked-resource-id="3342439" data-linked-resource-version="24" data-linked-resource-type="page">OV A1.3. General Administrative Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="35"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="36"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">1.4 Devices covered by Technical Documentation</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.4.1 List of type, sizes, configurations, variants including catalogue numbers covered by the submitted Technical Documentation</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>A complete list of product codes should be provided.</p></td><td class="confluenceTd"><p><a href="OV-A1.3.-General-Administrative-Information_3342439.html" data-linked-resource-id="3342439" data-linked-resource-version="24" data-linked-resource-type="page">OV A1.3. General Administrative Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="37"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="38"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse"> 1.5 Classification</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.5.1 Classification of the device including all the applicable rules and relevant rationales</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p><p>Annex VIII</p></td><td class="confluenceTd"><p>Indicate the device classification and rationale per MDR Annex VIII. The rationale should address each point of the selected classification rule. If multiple classification rules apply, all should be identified and the strictest rules resulting in the higher classification shall apply.</p><p>If the device contains multiple components that on their own might be classed differently, please note the higher classification shall apply.</p><p>If the device is a Well-Established Technology (WET) as per Articles 52.4 and</p><p>52.5 of MDR, a rationale supporting the determination of the device as a WET should be included considering any published guidance available on such devices.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf" rel="nofollow">MDCG 2021-24 Guidance on classification of medical devices</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/b45335c5-1679-4c71-a91c-fc7a4d37f12b_en?filename=md_mdcg_2019_11_guidance_qualification_classification_software_en.pdf" rel="nofollow">MDCG 2019-11 Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 – MDR and Regulation (EU) 2017/746 – IVDR</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf" rel="nofollow">IMDRF/SaMD WG/N12FINAL:2014 &quot;Software as a Medical Device&quot;: Possible Framework for Risk Categorization and Corresponding Considerations</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-131209-samd-key-definitions-140901.pdf" rel="nofollow">IMDRF/SaMD WG/N10FINAL:2013 Software as a Medical Device (SaMD): Key definitions</a></p></td><td class="confluenceTd"><p><a href="OV-A1.4.-Device-Classification-Rationale_3342453.html" data-linked-resource-id="3342453" data-linked-resource-version="12" data-linked-resource-type="page">OV A1.4. Device Classification Rationale</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="39"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="40"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse"> 1.6 Materials</span></strong></p></td></tr><tr><td class="confluenceTd"><p>1.6.1 Description and identification of key materials incorporated into the device</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The Technical Documentation should identify the raw materials incorporated into key functional elements of the device including information on any coatings that are critical for device safety and performance. The nature of contact with the human body (e.g. direct or indirect contact, contact with circulating body fluids) should be clearly identified.</p></td><td class="confluenceTd"><p> <a href="OV-A1.5.-Bill-of-Materials_3342467.html" data-linked-resource-id="3342467" data-linked-resource-version="29" data-linked-resource-type="page">OV A1.5. Bill of Materials</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="41"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="42"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.6.2 Identification of any tissues or cells of human or animal origin that may have been utilised in the manufacture of the device</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p>The submission should clearly indicate whether the device utilises or is used in conjunction with any human or animal- based products or other non-viable biological substances. Materials which are or include derivatives of human or animal origin should be clearly identified.</p></td><td class="confluenceTd"><p> <a href="OV-A1.1.-Device-Description_3342412.html" data-linked-resource-id="3342412" data-linked-resource-version="44" data-linked-resource-type="page">OV A1.1. Device Description</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="43"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="44"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>1.6.3 Bill of Materials</p></td><td class="confluenceTd"><p>Annex II, Section 1.1</p></td><td class="confluenceTd"><p><strong> </strong>Submission should include the device Bill of Materials.</p><p><a class="external-link" href="https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.imdrf.org%2Fsites%2Fdefault%2Ffiles%2F2023-04%2FPrinciples%2520and%2520Practices%2520for%2520Software%2520Bill%2520of%2520Materials%2520for%2520Medical%2520Device%2520Cybersecurity%2520%2528N73%2529.docx&amp;wdOrigin=BROWSELINK" rel="nofollow">IMDRF/CYBER WG/N73FINAL:2023 Principles and Practices for Software Bill of Materials for Medical Device Cybersecurity</a></p></td><td class="confluenceTd"><p><a href="OV-A1.5.-Bill-of-Materials_3342467.html" data-linked-resource-id="3342467" data-linked-resource-version="29" data-linked-resource-type="page">OV A1.5. Bill of Materials</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="45"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="46"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse"> 1.7 Market History</span></strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>1.7.1 Overview of relevant market history of the device (e.g. Date of first making available, Units sold, Previous models, Current and previous regulatory approvals)</p></td><td class="confluenceTd"><p>Annex II, Section 1.2</p></td><td class="confluenceTd"><p>All submissions should be accompanied by a market history to enable an understanding of the context of device development.</p><p>If the device is new and has never been marketed by the manufacturer anywhere in the world, please state this explicitly.</p><p>For existing devices:</p><ul><li><p>Ensure that a market history is provided indicating the nature and timing of any changes and that any associated documents (i.e. risk analyses, labelling, clinical evaluation reports, verification / validation data) account for these changes.</p></li><li><p>Provide evidence (e.g., Reference numbers of previous reviews) to demonstrate that notified body has been notified of all significant changes (if applicable).</p></li><li><p>For initial applications under MDR, confirm whether the device has been previously marketed under MDD and whether any changes have been made in comparison to the MDD-certified device</p></li><li><p>Market history should include EU and approvals in other geographies.</p></li><li><p>If the device is a system, ensure that the number of units sold is broken down by device component and per year</p></li></ul><p>Provide Periodic Safety Update Report if applicable (see below)</p></td><td class="confluenceTd"><p> <a href="OV-A1.6.-Product-History-Record_3342483.html" data-linked-resource-id="3342483" data-linked-resource-version="43" data-linked-resource-type="page">OV A1.6. Product History Record</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="47"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="48"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>1.7.2 Overview of similar devices available in EU or other markets</p></td><td class="confluenceTd"><p>Annex II, Section 1.2</p></td><td class="confluenceTd"><p>Provide an overview of identified similar devices available on the EU or international markets, if such devices exist.</p></td><td class="confluenceTd"><p> <a href="OV-A1.7.-Similar-Devices_3342500.html" data-linked-resource-id="3342500" data-linked-resource-version="15" data-linked-resource-type="page">OV A1.7. Similar Devices</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="49"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="50"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p><strong>Part B: Information Supplied by the Manufacturer</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="584ff409-b5c1-4698-bf7d-7657a1bfd9e8" class="confluenceTable"><colgroup><col style="width: 357.0px;"/><col style="width: 279.0px;"/><col style="width: 472.0px;"/><col style="width: 476.0px;"/><col style="width: 213.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="2"><li><p><strong><span class="legacy-color-text-inverse">Information Supplied by the Manufacturer</span></strong></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">2.1 User Information</span></strong></p></td></tr><tr><td class="confluenceTd"><p>2.1.1 Device or Product labelling</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td rowspan="5" class="confluenceTd"><p>Medical devices generally use multiple levels of labelling and it is recognised that not all devices may have the different levels of packaging specified in this section or different terms may be used than those specified here.</p><p>Legible versions of all applicable levels of labels should be provided (e.g. secondary pack, primary pack) and should be representative of the finished form, showing all included symbols.</p><p>If possible, provide drawings with the packaging configuration (showing placement of all labels) and label specifications.</p><p>The position of labels on the finished product should be clear. If the device has a sterile package, clearly identify the label for the sterile package. If any of the packaging is printed with information for the user (including pictures / schematics of the device) this should also be provided.</p><p>Ensure that any specific requirements of relevant harmonised standards or CS are addressed in the labels and information for use.</p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/2024-04/IMDRF%20GRRP%20WG%20N52%20%28Edition%202%29.pdf" rel="nofollow">IMDRF GRRP WG N52 (Edition 2) Principles of Labeling for Medical Devices and IVD Medical Devices</a></p></td><td rowspan="5" class="confluenceTd"><p><a href="OV-B.2.2.-Labelling_3342534.html" data-linked-resource-id="3342534" data-linked-resource-version="38" data-linked-resource-type="page">OV B.2.2. Labelling</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="51"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="52"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>2.1.2 Sterile packaging labelling</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="53"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="54"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>2.1.3 Single unit packaging labelling</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="55"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="56"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.4 Sales packaging labelling</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="57"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="58"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>2.1.5 Transport packaging labelling</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="59"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="60"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>2.1.6 Instructions for use / Device Operating Manual(s)</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p>Manufacturers must ensure that the information within the IFUs, especially related to intended purpose, indications, contra-indications, and other safety related information such as side effects, warnings is aligned with similar information from other sections such as risk management, clinical evaluation.</p><p>IFUs must contain all the information required as per applicable requirements specified within GSPR 23.</p><p>Manufacturers must as a minimum submit the English version at the time of application.</p></td><td class="confluenceTd"><p><a href="OV-B2.1.-User-Manuals_3342548.html" data-linked-resource-id="3342548" data-linked-resource-version="35" data-linked-resource-type="page">OV B2.1. User Manuals</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="61"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="62"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.7 Patient handbook</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p><strong> </strong>Some devices incorporate all the information relevant for the patient/user within the IFU itself. Some devices are accompanied by a patient handbook with additional instructions specific to the patient, for example with devices (or parts, components of the devices) that are patient operated. If the device is supplied with a patient handbook, this should be provided.</p></td><td class="confluenceTd"><p><a href="OV-B2.1.-User-Manuals_3342548.html" data-linked-resource-id="3342548" data-linked-resource-version="35" data-linked-resource-type="page">OV B2.1. User Manuals</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="63"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="64"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.8 Physicians handbook</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p>If a separate physicians’ handbook is relevant for the device, this should be provided.</p></td><td class="confluenceTd"><p><a href="OV-B2.1.-User-Manuals_3342548.html" data-linked-resource-id="3342548" data-linked-resource-version="35" data-linked-resource-type="page">OV B2.1. User Manuals</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="65"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="66"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.9 Implant card information</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p><strong> </strong>If applicable, the implant card and other information per Article 18 of MDR, and any additional information as specified in the MDCG guidance on Implant cards should be included. The location of the implant card within the device or system packaging should be clearly specified. The planned approach for translation of any information not in harmonized symbols should be described if applicable.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="67"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="68"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>2.1.10 Electronic IFU (e-IFU) information (if applicable, and as per (EU) 207/2012)</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p>If electronic IFU will be utilised, ensure compliance has been clearly outlined and evidence included to demonstrate compliance with all relevant aspects of Regulation 207/2012.</p></td><td class="confluenceTd"><p><a href="OV-B2.1.-User-Manuals_3342548.html" data-linked-resource-id="3342548" data-linked-resource-version="35" data-linked-resource-type="page">OV B2.1. User Manuals</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="69"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="70"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.11 Copies of promotional materials (that mention that the device fulfils the requirements of CE marking) including any that make specific claims related to the device</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p>Only marketing literature that mention that the device fulfils the requirements of CE marking or includes the CE mark itself is required to be provided.</p><p>Supporting evidence should be provided in the relevant pre-clinical and clinical sections to substantiate any claims made in the labelling or marketing literature.</p></td><td class="confluenceTd"><p><a href="3342517.html" data-linked-resource-id="3342517" data-linked-resource-version="11" data-linked-resource-type="page">OV Part B: Information Supplied by the Manufacturer</a> </p><p><a href="OV-B2.1.-User-Manuals_3342548.html" data-linked-resource-id="3342548" data-linked-resource-version="35" data-linked-resource-type="page">OV B2.1. User Manuals</a> </p><p><a href="OV-B2.1.1-Instructions-for-Use---Users_165445633.html" data-linked-resource-id="165445633" data-linked-resource-version="53" data-linked-resource-type="page">OV B2.1.1 Instructions for Use - Users</a> </p><p><a href="OV-B2.1.2-Instructions-for-Use---Supervisors_144736257.html" data-linked-resource-id="144736257" data-linked-resource-version="27" data-linked-resource-type="page">OV B2.1.2 Instructions for Use - Supervisors</a> </p><p><a href="OV-B2.1.3-Instructions-for-Use---Organizations_165347329.html" data-linked-resource-id="165347329" data-linked-resource-version="22" data-linked-resource-type="page">OV B2.1.3 Instructions for Use - Organizations</a> </p><p><a href="OV-B.2.2.-Labelling_3342534.html" data-linked-resource-id="3342534" data-linked-resource-version="38" data-linked-resource-type="page">OV B.2.2. Labelling</a> </p><p><a href="OV-B2.3.-Marketing-Material_3342562.html" data-linked-resource-id="3342562" data-linked-resource-version="6" data-linked-resource-type="page">OV B2.3. Marketing Material</a> </p><p><a href="OV-B2.4-Informative-Videos_55443464.html" data-linked-resource-id="55443464" data-linked-resource-version="8" data-linked-resource-type="page">OV B2.4 Informative Videos</a> </p><p><a href="OV-B2.5-Informed-Consent-and-Privacy-Policy_144572417.html" data-linked-resource-id="144572417" data-linked-resource-version="8" data-linked-resource-type="page">OV B2.5 Informed Consent and Privacy Policy</a> </p><p><a href="OV-B2.6-Customer-Service_442630503.html" data-linked-resource-id="442630503" data-linked-resource-version="2" data-linked-resource-type="page">OV B2.6 Customer Service</a> </p><p> <a class="external-link" href="https://onalabs.com/en/onavital/" rel="nofollow">OnaVital | Onalabs</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="71"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="72"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>2.1.12 URL of the website where the IFU (and any other labelling information as relevant) will be made available as per GSPR 23.1</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p>GSPR 23.1 requires that information related to identification, and safety and performance of the device shall be made available and kept up to date on the manufacturer’s website if the manufacturer has a website.</p><p>The URL of the website where such information will be made available should be included.</p></td><td class="confluenceTd"><p> <a class="external-link" href="https://onalabs.com/en/onavital/" rel="nofollow">OnaVital | Onalabs</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="73"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="74"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p><strong> </strong></p><p><strong>Part C: Design and Manufacturing Information</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="551d4082-09b9-4bb9-bf61-86a551f40d64" class="confluenceTable"><colgroup><col style="width: 358.0px;"/><col style="width: 286.0px;"/><col style="width: 471.0px;"/><col style="width: 468.0px;"/><col style="width: 214.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="3"><li><p><strong><span class="legacy-color-text-inverse">Design and Manufacturing Information</span></strong></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">3.1 Design Stages</span></strong></p></td></tr><tr><td class="confluenceTd"><p>3.1.1 Summary of design stages applied to the device</p></td><td class="confluenceTd"><p>Annex II, Section 3.a</p></td><td class="confluenceTd"><p>MDR Annex II requires the manufacturer to provide “information to allow the design stages applied to the device” to be understood.</p><p>Include a description of the design phases the device has gone through and the history of any major changes to the design.</p><p>For previously marketed or “legacy” devices certified under the Directives and applying for MDR certification, it is critical to provide the following:</p><p>·     any changes in the design of the device as approved under the Directives vs the application under MDR</p><p>·     an explanation and a map of previously conducted testing and outline what testing is relevant to the current version of the device. If historic testing is referenced but a subsequent change was made and only some specifications were re-tested, please explain what test reports have superseded and should be reviewed for each relevant specification.</p></td><td class="confluenceTd"><p><a href="3342931.html" data-linked-resource-id="3342931" data-linked-resource-version="19" data-linked-resource-type="page">OV F10.1 Product Development Plan (v2.0.0)</a></p><p> <a href="OV-A1.6.-Product-History-Record_3342483.html" data-linked-resource-id="3342483" data-linked-resource-version="43" data-linked-resource-type="page">OV A1.6. Product History Record</a> </p><p>Documentation on the medical device design life-cycle processes implemented ( software design/development, maintenance/change management, risk management, configuration management, problem resolution, verification, and validation processes) and maintenance process documentation (software maintenance plan) is contained in the quality management system.</p><p>A detailed overview of the manufacturing is provided in child pages including:</p><ul><li><p>Software development process documentation (e.g. software development plan, software requirements specification, software architecture, software detailed design, software unit testing procedures/reports, software integration testing procedures/reports, and software system testing)</p></li><li><p>Software risk assessment documentation (e.g. software hazard analysis, software failure mode and effects analysis, fault tree analysis, traceability).</p></li><li><p>Validation documents for processes/inputs that can affect final product quality not contained in the quality management system.</p></li></ul></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="75"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="76"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">3.2 Product and Design specifications</span></strong></p></td></tr><tr><td class="confluenceTd"><p>3.2.1 Key product/design specifications of the device (To include component and raw material specifications, including packaging. Specifications should include grade, quality, reference codes, full supplier details as relevant)</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p>Overall, manufacturers should demonstrate that design requirements have been identified in accordance with the intended use, safety and performance requirements, risk assessments, and relevant harmonised and other key standards or CS.</p><p>The source of design requirements should be indicated. Although compliance to harmonised and other key standards is expected, please be aware that testing beyond that required by the standards may be necessary to demonstrate compliance of your device to the relevant Safety &amp; Performance Requirements. Design requirements should be mapped to the intended use, performance and risks identified for the device.</p><p>It is recognised that there may some overlap and crossover between information requested in this section and other related sections. If that is the case, Manufacturer may simply point to the relevant sections of the Technical Documentation where this information can be found.</p></td><td class="confluenceTd"><p><a href="OV-C3.1.-Requirements-Specification_3342597.html" data-linked-resource-id="3342597" data-linked-resource-version="76" data-linked-resource-type="page">OV C3.1. Requirements Specification</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="77"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="78"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.2.2 User requirements</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p><strong> </strong>Please clearly identify the user requirements for the device.</p></td><td class="confluenceTd"><p><a href="OV-C3.1.-Requirements-Specification_3342597.html" data-linked-resource-id="3342597" data-linked-resource-version="76" data-linked-resource-type="page">OV C3.1. Requirements Specification</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="79"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="80"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse"> 3.3 Manufacturing Information</span></strong></p></td></tr><tr><td class="confluenceTd"><p>3.3.1 Overview of the Manufacturing process which also identifies any critical processes involved, including, if relevant, whether sterilisation is conducted on- site or sub-contracted</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p>A detailed overview of the manufacturing processes should be provided. This should clearly identify any special or proprietary processes, and any subcontracted processes</p><p><strong> </strong>As a general principle if any of the information requested in the Manufacturing section is not available in English, Manufacturer should either provide translations or provide supplementary summary reports with translations of relevant information/sections or in cases where the information/reports are data heavy (or mainly graphical in nature) with very few words, Manufacturer may annotate English translations of relevant words within the reports.</p></td><td class="confluenceTd"><p><a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/44171265/OLQMS-WI004+-+Manufacture+and+receipt+of+product" data-linked-resource-id="44171265" data-linked-resource-version="10" data-linked-resource-type="page">OLQMS-WI004 - Manufacture and receipt of product</a> </p><p><a data-card-appearance="inline" href="https://onalabs.atlassian.net/wiki/pages/createpage.action?spaceKey=ONALABSQMS&amp;title=OLQMS-WI004.1%20-%20ONAVITAL%2B%20Assembly&amp;linkCreation=true&amp;fromPageId=3342576" rel="nofollow">https://onalabs.atlassian.net/wiki/pages/createpage.action?spaceKey=ONALABSQMS&amp;title=OLQMS-WI004.1%20-%20ONAVITAL%2B%20Assembly&amp;linkCreation=true&amp;fromPageId=3342576</a> </p><p><a href="OV-C3.4.-Product-Manufacturing-Definitions-and-Procedures_54132737.html" data-linked-resource-id="54132737" data-linked-resource-version="40" data-linked-resource-type="page">OV C3.4. Product Manufacturing Definitions and Procedures</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="81"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="82"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.3.2 Critical process verification protocols/plans</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td rowspan="2" class="confluenceTd"><p>Identify <u>critical</u> verified processes.</p><p>If verified and validated processes are documented in an overall Master Validation plan, please provide this document.</p><p><strong> </strong>As a part of the initial submission, Manufacturer should include verification protocols/plans/reports for processes that are verified (as opposed to validated) and are considered critical for the safety and performance of the device. BSI Reviewers may request this information for other verified processes (not originally included with the submission) during the review process if required.</p></td><td class="confluenceTd"><p><a href="3342917.html" data-linked-resource-id="3342917" data-linked-resource-version="5" data-linked-resource-type="page">OV F10. Validation and Verification (V &amp; V)</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="83"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="84"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.3.3 Critical process verification reports</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p> <a href="3342917.html" data-linked-resource-id="3342917" data-linked-resource-version="5" data-linked-resource-type="page">OV F10. Validation and Verification (V &amp; V)</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="85"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="86"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.3.4 Critical process validation protocols/plans</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td rowspan="2" class="confluenceTd"><p>Identify the <u>critical</u> validated processes.</p><p>If verified and validated processes are documented in an overall Master Validation plan, please provide this document.</p><p>As a part of the initial submission, Manufacturer should include validation protocols/plans/reports for processes that are validated and are considered critical for the safety and performance of the device. BSI Reviewers may request this information for other validated processes (not originally included with the submission) during the review process if required.</p></td><td class="confluenceTd"><p> <a href="3342917.html" data-linked-resource-id="3342917" data-linked-resource-version="5" data-linked-resource-type="page">OV F10. Validation and Verification (V &amp; V)</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="87"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="88"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.3.5 Critical process validation reports</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p> <a href="3342917.html" data-linked-resource-id="3342917" data-linked-resource-version="5" data-linked-resource-type="page">OV F10. Validation and Verification (V &amp; V)</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="89"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="90"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.3.6 Incoming inspections and acceptance criteria &amp; results from a sample batch</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td rowspan="3" class="confluenceTd"><p>MDR Annex VII Section 4.5.3 2nd indent requires that NBs examine the implementation by manufacturers of incoming, in-process and final checks and their results as a part of Technical Documentation assessment. Technical Documentation should include the following:</p><p>·     Acceptance criteria &amp; results of incoming inspections from a <u>sample</u> batch for the <u>critical</u> raw materials and/or sub-assemblies and/or components</p><p>·     Acceptance criteria &amp; results of in-process inspections from a <u>sample</u> batch for the <u>critical</u> processes identified in sections 3.3.2 and 3.3.3 above</p><p>·     Acceptance criteria &amp; results of final inspections from a <u>sample</u> batch for the finished devices</p><p>·     Identification of party responsible of inspections of subcontracted processes.</p></td><td class="confluenceTd"><p> <a href="OV-C3.3.-Product-Orders-and-Receipt-of-Goods_39649288.html" data-linked-resource-id="39649288" data-linked-resource-version="70" data-linked-resource-type="page">OV C3.3. Product Orders and Receipt of Goods</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="91"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="92"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.3.7 In-process inspections and acceptance criteria &amp; results from a sample batch</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p> <a href="OV-C3.3.-Product-Orders-and-Receipt-of-Goods_39649288.html" data-linked-resource-id="39649288" data-linked-resource-version="70" data-linked-resource-type="page">OV C3.3. Product Orders and Receipt of Goods</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="93"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="94"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.3.8 Final inspections and acceptance criteria &amp; results from a sample batch</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p> <a href="OV-C3.3.-Product-Orders-and-Receipt-of-Goods_39649288.html" data-linked-resource-id="39649288" data-linked-resource-version="70" data-linked-resource-type="page">OV C3.3. Product Orders and Receipt of Goods</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="95"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="96"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.3.9 Installation and Commissioning tests</p></td><td class="confluenceTd"><p>Annex II, Section 3.b</p></td><td class="confluenceTd"><p>If the device is required to be installed and/or commission at the user location, provide information on tests to be carried out as a part of the installation and commissioning of the device.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="97"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="98"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">3.4 Sites involved in design and manufacturing activities</span></strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.4.1 Legal Manufacturer (as per EUDAMED registration)</p></td><td class="confluenceTd"><p>Annex II, Section 3.c</p></td><td class="confluenceTd"><p><strong> </strong>The application should identify the name and location of the legal manufacturer who is placing the devices on the market. This should be consistent across the device labels, IFU and Declarations of Conformity. The Single Registration Number (SRN) of the legal manufacturer should be identified.</p></td><td class="confluenceTd"><p> <a href="OV-A1.3.-General-Administrative-Information_3342439.html" data-linked-resource-id="3342439" data-linked-resource-version="24" data-linked-resource-type="page">OV A1.3. General Administrative Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="99"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="100"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.4.2 European Representatives</p></td><td class="confluenceTd"><p>Annex II, Section 3.c</p></td><td class="confluenceTd"><p>The name and location of the EU Authorised Representative should be identified if required. Only one EU Representative should be identified, and this should be consistent across the device labels, IFU and Declarations of Conformity. The Single Registration Number (SRN) of the EU Authorised Representative should be identified.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="101"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="102"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.4.3 Site with Design responsibility</p></td><td class="confluenceTd"><p>Annex II, Section 3.c</p></td><td class="confluenceTd"><p>The site(s) responsible for design should be clearly identified. This may be the same as the legal manufacturer or may be another internal or external subcontractor site. If a site other than the legal manufacturer is responsible for design provide copies of their ISO 13485 certificates (see also 3.4.5 below)</p></td><td class="confluenceTd"><p> <a href="OV-A1.3.-General-Administrative-Information_3342439.html" data-linked-resource-id="3342439" data-linked-resource-version="24" data-linked-resource-type="page">OV A1.3. General Administrative Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="103"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="104"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>3.4.4 Sterilisation subcontractors</p></td><td class="confluenceTd"><p>Annex II, Section 3.c</p></td><td rowspan="2" class="confluenceTd"><p>The name and address of any critical subcontractors or crucial suppliers (as per Commission Recommendation 2013/473/EU) should be identified, along with the service or material supplied by each.</p><p>Provide copies of critical subcontractor ISO 13485 certificates. If a critical subcontractor does not have an ISO 13485 certificate from a Notified Body, additional supplier audits may need to be arranged</p><p>If you have changed a supplier please include a justification for identifying the supplier as a Critical Subcontractor, Crucial supplier or neither based on the guidance in MDF4102. If you remove a supplier, provide a justification for removing them.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="105"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="106"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>3.4.5 Other critical subcontractors and crucial suppliers relevant to the device(s) including copies of certification held by such entities</p></td><td class="confluenceTd"><p>Annex II, Section 3.c</p></td><td class="confluenceTd"><p> <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753685/OLQMS-REC001.1+-+Approved+Supplier+Register" data-linked-resource-id="2753685" data-linked-resource-version="62" data-linked-resource-type="page">OLQMS-REC001.1 - Approved Supplier Register</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="107"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="108"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p><strong>Part D: General Safety and Performance Requirements</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="0f10ef59-926a-4991-982f-a9204a0d6279" class="confluenceTable"><colgroup><col style="width: 358.0px;"/><col style="width: 286.0px;"/><col style="width: 466.0px;"/><col style="width: 326.0px;"/><col style="width: 362.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="4"><li><p><strong><span class="legacy-color-text-inverse">General Safety and Performance Requirements</span></strong></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">4.1 Demonstration of Conformity with GSPRs</span></strong></p></td></tr><tr><td class="confluenceTd"><p>4.1.1 GSPR checklist (or in any other format) that meets the requirements of MDR Annex II section 4</p></td><td class="confluenceTd"><p>Annex I</p><p>Annex II, Section 4.a, 4.b and 4.d</p></td><td class="confluenceTd"><p>MDR Annex II Section 4 requires the Technical Documentation to include a demonstration of conformity with the applicable General Safety &amp; Performance Requirements (GSPRs) of Annex I, including:</p><p>·     The GSPRs that apply to the device and an explanation as to why others do not apply</p><p>·     The method or methods used to demonstrate conformity with each applicable GSPR</p><p>·     Harmonised standards, CS, or other solutions applied</p><p>·     The precise identity of the controlled documents offering evidence of conformity with each harmonised standard, CS, or other method applied to demonstrate conformity with the GSPR. This shall include a cross- reference to the location of that document within the full Technical Documentation and summary Technical Documentation (if applicable).</p><p>It is recommended that the above information is provided in the form of a checklist against the GSPRs to show how compliance with the GSPRs has been achieved.</p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/2024-06/IMDRF%20GRRP%20WG%20N47%20%28Edition%202%29%20%285%29.pdf" rel="nofollow">IMDRF/GRRP WG/N47 FINAL:2024 (Edition 2) Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices</a></p></td><td class="confluenceTd"><p><a href="OV-D4.1.-GSPR-Checklist_3342726.html" data-linked-resource-id="3342726" data-linked-resource-version="13" data-linked-resource-type="page">OV D4.1. GSPR Checklist</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="109"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="110"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>4.1.2 Standards applied including whether applied in part or full along with the version/date of the standards applied</p></td><td class="confluenceTd"><p>Annex II, Section 4.c</p></td><td rowspan="2" class="confluenceTd"><p>The documentation should demonstrate that all Common Specifications (CS) and relevant standards, both harmonised and product specific, have been considered. This is usually accomplished by means of a list of applicable standards and CS, as well as by reference to appropriate standards and CS in the appropriate documents (e.g. test reports).</p><p>·     When identifying applicable standards or CS, indicate if full or partial compliance is being claimed.</p><p>·     Where key standards or CS have not been applied or not been applied in full, appropriate justification should be provided in the Technical Documentation. A summary or gap analysis regarding ability to comply with associated General Safety &amp; Performance Requirements (Annex I), and a risk analysis &amp; conclusion of acceptability of any compliance gaps should be provided.</p><p>·     Indicate if there have been any changes to applicable standards or CS since the Technical Documentation was last reviewed by a notified body. The Technical Documentation should continue to demonstrate that the files meet the state of the art, including consideration of revised or replaced standards or CS.</p></td><td class="confluenceTd"><p> <a href="OV-D4.2.-Standards-and-Common-Specifications-applied_3342740.html" data-linked-resource-id="3342740" data-linked-resource-version="14" data-linked-resource-type="page">OV D4.2. Standards and Common Specifications applied</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="111"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="112"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>4.1.3 Common Specifications applied</p></td><td class="confluenceTd"><p>Annex II, Section 4.c</p></td><td class="confluenceTd"><p> <a href="OV-D4.2.-Standards-and-Common-Specifications-applied_3342740.html" data-linked-resource-id="3342740" data-linked-resource-version="14" data-linked-resource-type="page">OV D4.2. Standards and Common Specifications applied</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="113"><span class="placeholder-inline-tasks"> Complete</span></li><li data-inline-task-id="114"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>4.1.4 Other applicable Regulations &amp; Directives (PPE, Machinery, e-IFU regulation)</p></td><td class="confluenceTd"><p>Annex II, Section 4.c</p></td><td class="confluenceTd"><p>Indicate which Regulations and / or Directives apply. If a device is governed by multiple regulations or directives, all applicable regulations / directives should be identified. For example:</p><p>·     If the device is intended to be used in accordance with both the MDR and Regulation (EU) 2016/425 (previously 89/686/EEC) for personal protective equipment, ensure that fulfilment of the relevant basic health and safety requirements of (EU) 2016/425 have been met.</p><p>·     If the device is also machinery (within Article 2a of 2006/42/EC), ensure fulfilment of the relevant basic health and safety requirements of Directive 2006/42/EC Annex I have been met.</p><p>·     If the devices have been impacted by subsequent directives / regulations (e.g. 2005/50/EC, 2003/12/EC, 722/2012, 207/2012) ensure that these are identified, and any new requirements met.</p></td><td class="confluenceTd"><p> <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2752937/External+References" data-linked-resource-id="2752937" data-linked-resource-version="1" data-linked-resource-type="page">External References</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="115"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="116"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p><strong>Part E: Benefit-Risk Management</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="4a06ad21-8a0f-4439-a594-4596d6b60abb" class="confluenceTable"><colgroup><col style="width: 353.0px;"/><col style="width: 293.0px;"/><col style="width: 470.0px;"/><col style="width: 433.0px;"/><col style="width: 247.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="5"><li><p><strong><span class="legacy-color-text-inverse">Benefit-Risk Analysis and Risk Management</span></strong></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><h3 id="OVONAVITALMedicalDeviceFileChecklist-5.1Benefit-RiskAnalysis"><strong><span class="legacy-color-text-inverse">5.1 Benefit-Risk Analysis</span></strong></h3></td></tr><tr><td class="confluenceTd"><p>5.1.1 Benefit-risk analysis (as per GSPR #1 and #8)</p></td><td class="confluenceTd"><p>Annex II, Section 5.a</p></td><td class="confluenceTd"><p><strong> </strong>The risk management documentation should provide a template for preparedness, indicating whether controls (i.e. process validations, biocompatibility, sterilisation, clinical, shelf-life or other key verification / validation tests) have reduced all risks as low as possible (vs. as low as reasonably practicable) to acceptable levels in light of state-of-the-art for the product(s) under review. The assessment must demonstrate that the benefits outweigh all the residual risks when the device is used as intended.</p></td><td class="confluenceTd"><p> <a href="OV-E5.1.-Risk-Management-Plan_33816587.html" data-linked-resource-id="33816587" data-linked-resource-version="8" data-linked-resource-type="page">OV E5.1. Risk Management Plan</a> </p><p><a href="OV-E5.5.-Risk-Assessment-and-Evaluation_3342773.html" data-linked-resource-id="3342773" data-linked-resource-version="27" data-linked-resource-type="page">OV E5.5. Risk Assessment and Evaluation</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="117"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="118"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">5.2 Risk Management</span></strong></p></td></tr><tr><td class="confluenceTd"><p>5.2.1 Risk management procedure</p></td><td class="confluenceTd"><p>Annex II, Section 5.a</p></td><td class="confluenceTd"><p>A thorough design and process Risk Management assessment should be conducted for the entire lifecycle of the device (from initial design concept up to and including device disposal). This should be updated (as appropriate) with data from PMS.</p><p>The analysis must demonstrate that appropriate controls (design out then protective measures) have been applied to all risks.</p><p>Provide copies of the appropriate risk management documents including a copy of risk management procedure.</p></td><td class="confluenceTd"><p> <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753516/OLQMS-PRO003+-+Risk+Management+SOP" data-linked-resource-id="2753516" data-linked-resource-version="17" data-linked-resource-type="page">OLQMS-PRO003 - Risk Management SOP</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="119"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="120"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>5.2.2 Risk management plan</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p><strong> </strong>Provide the risk management plan associated with the device.</p></td><td class="confluenceTd"><p> <a href="OV-E5.1.-Risk-Management-Plan_33816587.html" data-linked-resource-id="33816587" data-linked-resource-version="8" data-linked-resource-type="page">OV E5.1. Risk Management Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="121"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="122"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>5.2.3 Risk scoring system</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p><strong> </strong>A copy of Risk Management Procedure(s) that include the definition of any rating systems used for risk analysis and risk acceptability should be provided. If this is part of a different document such as the risk management plan or maintained as a separate document that is specific for the subject device, then the relevant information must be included.</p></td><td class="confluenceTd"><p> <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753516/OLQMS-PRO003+-+Risk+Management+SOP" data-linked-resource-id="2753516" data-linked-resource-version="17" data-linked-resource-type="page">OLQMS-PRO003 - Risk Management SOP</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="123"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="124"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>5.2.4 Design risk assessment</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p>Provide the documented risk assessment for the design aspects of the device.</p><p>Assess whether any design changes add new hazards or reduce the likelihood of occurrence of existing hazards, irrespective of whether the risk assessment has changed.</p></td><td class="confluenceTd"><p> <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753516/OLQMS-PRO003+-+Risk+Management+SOP" data-linked-resource-id="2753516" data-linked-resource-version="17" data-linked-resource-type="page">OLQMS-PRO003 - Risk Management SOP</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="125"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="126"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>5.2.5 Production/process risk assessment</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p>Provide the documented risk assessment for the production / manufacturing process aspects of the device.</p></td><td class="confluenceTd"><p> <a href="OV-C3.4.-Product-Manufacturing-Definitions-and-Procedures_54132737.html" data-linked-resource-id="54132737" data-linked-resource-version="40" data-linked-resource-type="page">OV C3.4. Product Manufacturing Definitions and Procedures</a> </p><p><a href="OV-E5.5.-Risk-Assessment-and-Evaluation_3342773.html" data-linked-resource-id="3342773" data-linked-resource-version="27" data-linked-resource-type="page">OV E5.5. Risk Assessment and Evaluation</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="127"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="128"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>5.2.6 Clinical/Application/Product risk assessment</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p>Provide the documented risk assessment for the clinical usage / application aspects of the device.</p><p>Note that for single-use devices, GSPR 23.4(p) requires the risks of re-use to be addressed in a specific section of the risk management and this should be identifiable.</p></td><td class="confluenceTd"><p> <a href="OV-E5.5.-Risk-Assessment-and-Evaluation_3342773.html" data-linked-resource-id="3342773" data-linked-resource-version="27" data-linked-resource-type="page">OV E5.5. Risk Assessment and Evaluation</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="129"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="130"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>5.2.7 Risk management report</p></td><td class="confluenceTd"><p>Annex II, Section 5.b</p></td><td class="confluenceTd"><p><strong> </strong>Provide the risk management report associated with the device.</p></td><td class="confluenceTd"><p> <a href="OV-E5.6.-Risk-Management-Report_91553793.html" data-linked-resource-id="91553793" data-linked-resource-version="7" data-linked-resource-type="page">OV E5.6. Risk Management Report</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="131"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="132"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p>Part F: Pre-Clinical Information</p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="c13245a8-f6a9-432a-bcbe-dca7f562715f" class="confluenceTable"><colgroup><col style="width: 358.0px;"/><col style="width: 290.0px;"/><col style="width: 463.0px;"/><col style="width: 466.0px;"/><col style="width: 219.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><ol start="6"><li><p><strong><span class="legacy-color-text-inverse">Product Verification and Validation</span></strong></p></li></ol></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.1 Biocompatibility</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.1.1 Biological safety risk assessment (either stand- alone or as a part of the risk management section)</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.a /b</p></td><td class="confluenceTd"><p><strong> </strong>Provide a biological safety risk assessment for the device. As specified, this may either be a stand-alone document or part of the risk management section.</p></td><td class="confluenceTd"><p> <a href="OV-E5.5.-Risk-Assessment-and-Evaluation_3342773.html" data-linked-resource-id="3342773" data-linked-resource-version="27" data-linked-resource-type="page">OV E5.5. Risk Assessment and Evaluation</a> </p><p><a href="3342787.html" data-linked-resource-id="3342787" data-linked-resource-version="4" data-linked-resource-type="page">OV Part F: Pre-Clinical Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="133"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="134"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.1.2 Material characterisation test protocols and reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.a /b</p></td><td class="confluenceTd"><p>Include all material characterisation test protocols and reports.</p><p>·       In particular, for devices specified in Annex I GSPR 10.4.1 containing or incorporating carcinogenic, mutagenic, or toxic to reproduction (“CMR”) substances of category 1A or 1B (in accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008), or substances having endocrine- disrupting properties must meet requirements in the MDR for justification of the presence of these substances. Specific labelling requirements must also be met for these substances (GSPR 10.4.5).</p><p>Where this information on CMR or endocrine-disrupting substances is provided by suppliers, manufacturers should confirm the completeness of this information and describe any additional testing or analysis performed to confirm the information and the presence of these substances.</p><p><a class="external-link" href="https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32008R1272" rel="nofollow">Regulation - 1272/2008 - EN - clp regulation - EUR-Lex</a></p></td><td class="confluenceTd"><p><a href="3342787.html" data-linked-resource-id="3342787" data-linked-resource-version="4" data-linked-resource-type="page">OV Part F: Pre-Clinical Information</a> </p><p><a href="OV-F1.-Biocompatibility_3342804.html" data-linked-resource-id="3342804" data-linked-resource-version="12" data-linked-resource-type="page">OV F1. Biocompatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="135"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="136"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.1.3 Biocompatibility test protocols and reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.a /b</p></td><td class="confluenceTd"><p><strong> </strong>The assessment should categorise the nature and duration of body contact for each component and identify any tests that are required or can be waived to establish evidence of compatibility. Justifications must be included for any tests that have been waived.</p></td><td class="confluenceTd"><p><a href="3342787.html" data-linked-resource-id="3342787" data-linked-resource-version="4" data-linked-resource-type="page">OV Part F: Pre-Clinical Information</a>  </p><p><a href="OV-F1.-Biocompatibility_3342804.html" data-linked-resource-id="3342804" data-linked-resource-version="12" data-linked-resource-type="page">OV F1. Biocompatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="137"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="138"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.1.4 Overall biological safety assessment</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.a /b</p></td><td class="confluenceTd"><p>Biological safety assessments should be undertaken in accordance with ISO 10993-1. See Clause 7 of this standard for guidance with respect to appropriate report content for the overall biological safety assessment.</p><p>Biological safety assessments should include evidence of compliance for the finished device (including consideration of all materials and all manufacturing steps). It is not enough to simply state that devices have been manufactured from materials of well-established biological safety – an assessment which considers the impact of manufacturing and sterilisation processes, intended use must be provided.</p></td><td class="confluenceTd"><p> <a href="3342787.html" data-linked-resource-id="3342787" data-linked-resource-version="4" data-linked-resource-type="page">OV Part F: Pre-Clinical Information</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="139"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="140"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.1.5 CVs of the expert assessors involved in the biological safety assessment to establish competence</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.a /b</p></td><td class="confluenceTd"><p><strong> </strong>A justification should be provided regarding the qualifications of those involved in planning, executing, and analysing the biocompatibility assessment.</p></td><td class="confluenceTd"><p> <a href="OV-F1.-Biocompatibility_3342804.html" data-linked-resource-id="3342804" data-linked-resource-version="12" data-linked-resource-type="page">OV F1. Biocompatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="141"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="142"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.2 Electrical safety and electromagnetic compatibility (EMC)</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.2.1 Electrical safety test protocols</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td rowspan="2" class="confluenceTd"><p>Please provide the test protocols and reports for electrical safety testing, if applicable to the device.</p><p>Ensure the provided documentation clearly defines the ESSENTIAL PERFORMANCE of the device and is in line with the risk management documentation.</p><p>If a subset of devices has been selected for testing and this subset is intended to represent a larger range of devices, provide supporting documentation that demonstrates how the configurations that have been tested can be considered representative of the wider set of devices/configurations.</p></td><td class="confluenceTd"><p> <a href="OV-F2.-Electrical-safety-and-electromagnetic-compatibility_3342818.html" data-linked-resource-id="3342818" data-linked-resource-version="11" data-linked-resource-type="page">OV F2. Electrical safety and electromagnetic compatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="143"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="144"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.2.2 Electrical safety test reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p> <a href="OV-F2.-Electrical-safety-and-electromagnetic-compatibility_3342818.html" data-linked-resource-id="3342818" data-linked-resource-version="11" data-linked-resource-type="page">OV F2. Electrical safety and electromagnetic compatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="145"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="146"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.2.3 EMC test protocols</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td rowspan="2" class="confluenceTd"><p>Please provide the test protocols and reports for EMC testing, if applicable to the device.</p><p>Ensure the provided documentation clearly defines the ESSENTIAL PERFORMANCE of the device and is in line with the risk management documentation.</p><p>If a subset of devices has been selected for testing and this subset is intended to represent a larger range of devices, provide supporting documentation that demonstrates how the configurations that have been tested can be considered representative of the wider set of devices/configurations.</p></td><td class="confluenceTd"><p> <a href="OV-F2.-Electrical-safety-and-electromagnetic-compatibility_3342818.html" data-linked-resource-id="3342818" data-linked-resource-version="11" data-linked-resource-type="page">OV F2. Electrical safety and electromagnetic compatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="147"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="148"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.2.4 EMC test reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p> <a href="OV-F2.-Electrical-safety-and-electromagnetic-compatibility_3342818.html" data-linked-resource-id="3342818" data-linked-resource-version="11" data-linked-resource-type="page">OV F2. Electrical safety and electromagnetic compatibility</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="149"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="150"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.3 Software Verification and Validation</span></strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.3.1 EN 62304 checklist</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Appropriate documentation is required if the medical devices are either stand-alone software or rely upon software. Provide a checklist against the requirements of EN 62304.</p><p>If medical device is stand-alone software, guidance for the qualification and classification of the software can be found in MDCG 2019-11 and Classification guidance documents.</p><p>There should be a rationale for why the software is a medical device and for its classification. If applicable, the software should be broken down into modules, some that have a medical purpose and some that do not. The modules with a medical purpose must comply with the requirements of the medical device directives and must carry the CE marking. The non-medical device modules are not subject to the requirements for medical devices.</p><p>Ensure all relevant harmonised and non-harmonised software standards have been considered. Ensure the software systems/modules/items have been assigned safety classifications based on standards.</p><p>Include documentation on the medical device software life-cycle processes implemented (e.g. software design/development, maintenance/change management, risk management, configuration management, problem resolution, verification, and validation processes). If software is intended to be used with mobile computing platforms, include information on specific features of mobile platforms demonstrating compliance with GSPR 17.3.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/b45335c5-1679-4c71-a91c-fc7a4d37f12b_en?filename=md_mdcg_2019_11_guidance_qualification_classification_software_en.pdf" rel="nofollow">MDCG 2019-11 Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 – MDR and Regulation (EU) 2017/746 – IVDR</a></p></td><td class="confluenceTd"><p /></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="151"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="152"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.3.2 Software development plan</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Include software development procedures and the software development plan (SDP) detailing the activities completed as part of the software development lifecycle (e.g. software requirements specification, software architecture, software detailed design, software unit testing procedures/reports, software integration testing procedures/reports, and software system testing procedures/reports). Documentation related to the software maintenance and software configuration management processes should also be provided (e.g. software maintenance plan, configuration management plan).</p><p>Note:: Some documentation may or may not be required per the standards based on software system/module/item risk classification.</p></td><td class="confluenceTd"><p> <a href="OV-C3.4.-Product-Manufacturing-Definitions-and-Procedures_54132737.html" data-linked-resource-id="54132737" data-linked-resource-version="40" data-linked-resource-type="page">OV C3.4. Product Manufacturing Definitions and Procedures</a> </p><p><a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753633/OLQMS-PRO012+-+Product+Lifecycle+SOP" data-linked-resource-id="2753633" data-linked-resource-version="31" data-linked-resource-type="page">OLQMS-PRO012 - Product Lifecycle SOP</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="153"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="154"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.3.3 Software requirements analysis</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Include the software requirements specification (SRS). An explanation regarding how the software requirements have been derived from higher level system requirements should be included and traceability to those higher-level requirements should be established. Risk controls implemented in software should also be included in the SRS. Software requirements should be clearly stated, unambiguous, and should be readily translatable into verification acceptance criteria.</p><p>NOTE: See EN 62304 Clause 5.2.2 for generally expected categories that should be covered in the software requirements specification.</p></td><td class="confluenceTd"><p><a href="3342576.html" data-linked-resource-id="3342576" data-linked-resource-version="8" data-linked-resource-type="page">OV Part C: Design and Manufacturing Information</a> </p><p><a href="OV-C3.1.-Requirements-Specification_3342597.html" data-linked-resource-id="3342597" data-linked-resource-version="76" data-linked-resource-type="page">OV C3.1. Requirements Specification</a> </p><p><a href="OV-C3.2.-Detailed-Design_3342611.html" data-linked-resource-id="3342611" data-linked-resource-version="2" data-linked-resource-type="page">OV C3.2. Detailed Design</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="155"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="156"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.3.5 Software detailed design</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>For EN 62304 Software Safety Class ‘B’ and ‘C’ software, include the software detailed design (SDD). The software detailed design (SDD) represents a further refinement of the software architecture described in 6.3.4. The SDD should clearly identify the SOFTWARE UNITS that are derived from the SOFTWARE ITEMS specified in the software architecture. The SDD should provide details regarding the function and expected inputs and outputs of the SOFTWARE UNITS. In general, the SDD should provide enough detail to allow correct implementation of the SOFTWARE UNITS and their expected interfaces.</p></td><td class="confluenceTd"><p>  <span style="background-color: rgb(254,222,200);">Incomplete.</span></p><p><span style="background-color: rgb(254,222,200);">Not documented or signposted.</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="157"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="158"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.3.6 Software unit implementation and verification</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p><strong> </strong>For EN 62304 Software Safety Class ‘B’ and ‘C’ software, include evidence of SOFTWARE UNIT verification. These may include unit test protocols/scripts and associated reports. Note that this type of testing is usually considered “white box” testing in that detailed knowledge of the underlying software code is usually required to properly design the unit verification tests. Where automated testing has been used to perform verification activities, include the test scripts and the test log results in the submission documentation.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="159"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="160"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.3.7 Software integration and integration testing</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p><strong> </strong>For EN 62304 Software Safety Class ‘B’ and ‘C’ software, include evidence that software integration testing has been performed. Please note that this testing should be aimed at showing how the SOFTWARE ITEMS (which are internal to the SOFTWARE SYSTEM) function as expected when integrated together. Areas to investigate can include, for example, expected timing, functioning of internal and external interfaces, and testing under abnormal conditions/foreseeable misuse. This testing is typically not conducted on the final, compiled code and will normally make use of a test/simulation environment where various combinations of SOFTWARE ITEMS can be tested in isolation. It is permissible to combine software integration testing with software system testing (per 6.3.8 below). Where this strategy has been employed to cover the requirement to perform software integration testing, this should be clearly explained in the submission documentation. Where automated testing has been used to perform verification activities, include the test scripts and the test log results in the submission documentation.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="161"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="162"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.3.8 Software systems testing</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p><strong> </strong>Include the software system test protocol(s) and report(s). This testing should demonstrate that each of the software requirements (per 6.3.3) have been verified. It is expected that traceability between the software requirements and the software test cases/test procedures should be established. This testing is typically conducted on the final, compiled SOFTWARE SYSTEM. Input stimuli, expected outcomes, pass/fail criteria, and test procedures should be clearly established in the test documentation.</p><p>Where test failures or deviations have been encountered, these should be clearly documented and justified in the provided reports. Where automated testing has been used to perform verification activities, include the test scripts and the test log results in the submission documentation.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="163"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="164"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.3.9 Software release</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Include the <u>list of known residual anomalies</u>. The following information on each remaining anomaly should be included:</p><p>·     Unique Identifier</p><p>·     Brief description of the issue</p><p>·     Severity/Risk Level</p><p>·     Justification for why it is acceptable to release the software with the anomaly</p><p>Also include documentation showing how the released software was created (e.g. procedure and environment used create the released software). The final released software version number should be identified in this documentation. Documentation explaining how the released software is archived and how it can be reliably delivered (e.g. to the manufacturing environment or to the user of the software) should be included.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="165"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="166"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.3.10 Software risk assessment</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Include software risk assessment documentation (e.g. software hazard analysis, software failure mode and effects analysis, fault tree analysis, traceability).</p><p>Note: Some documentation may or may not be required per the standards based on software system/module/item risk classification.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="167"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="168"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.3.11 Cybersecurity documentation</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p>Include documentation related to the design and maintenance of the cybersecurity features of the medical device. Documentation should include the security risk management plan, security risk assessment, and verification/validation evidence for the identified security risk controls.</p><p>Threats and the associated protections needed to ensure the <strong>confidentiality</strong>, <strong>integrity</strong>, and <strong>availability </strong>of the data, function and services of the medical device should be considered. Documentation showing how cybersecurity threats are monitored and responded to as part of the post-market surveillance of the device should also be provided.</p><p>NOTE: See MDCG 2019-16 Guidance on Cybersecurity for medical devices.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/b23b362f-8a56-434c-922a-5b3ca4d0a7a1_en?filename=md_cybersecurity_en.pdf" rel="nofollow">MDCG 2019-16 Rev.1 Guidance on Cybersecurity for medical devices</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-200318-pp-mdc-n60.pdf" rel="nofollow">IMDRF/CYBER WG/N60FINAL:2020 Principles and Practices for Medical Device Cybersecurity</a></p></td><td class="confluenceTd"><p><a href="OV-F9.-Cybersecurity_3342860.html" data-linked-resource-id="3342860" data-linked-resource-version="9" data-linked-resource-type="page">OV F9. Cybersecurity</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="169"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="170"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.4 Stability including shelf life</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.4.1 Stability/shelf-life validation protocols (to include both device and packaging performance)</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td rowspan="2" class="confluenceTd"><p>·     Shelf life is normally considered to be the time the device can be kept in the packaging prior to its first use. This is not the same as “Lifetime”.</p><p>·     Shelf-life testing is not restricted to the packaging. The device itself should be subject to shelf life testing, or a rationale provided to demonstrate why its characteristics are not expected to degrade over the claimed shelf life.</p><p>·     If shelf life testing is based on accelerated age testing, this should be accompanied by a plan for real time testing. Real time testing should be underway by the time documentation is submitted for review.</p><p>·     Extensions to shelf life for Class III devices and Class IIb implantable devices (non-WET) must be reported to BSI for review and certificate re- issue.</p><p>Shelf Life Validation should include:</p><p>·     Protocol (with acceptance criteria for each test performed) and appropriate test references;</p><p>·     A clear statement of the intended shelf life;</p><p>·     A clear statement defining the sterilisation status of the test samples (1X, 2X sterilised);</p><p>·     A summary of the accelerated aging parameters (temperature and humidity) and how the aging times were calculated;</p><p>·     A statement covering Real Time Aging plans;</p><p>·     A clear delineation of statistically significant sample quantities;</p><p>·     Actual physical/microbiological test data reports supporting the expiration date, or post aging, claim (peel testing, burst testing, dye testing, etc.);</p><p>·     A summary of the ship testing/transit simulation testing conducted and applicable test reports.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="171"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="172"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.4.2 Stability/shelf-life validation results and reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.b</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="173"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="174"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.5 Performance and Safety – Design Verification and Validations</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.5.1 Design control matrix</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>A design verification / validation strategy document and / or summary of the outcomes should be provided. Verification / validation results should be provided for each design requirement. If compliance has been demonstrated without testing, an appropriate rationale should be provided.</p><p>For previously marketed or “legacy” devices applying for MDR certification, it is critical to provide an explanation and map of previously conducted testing and outline what testing is relevant to the current version of the device. If historic testing is referenced but a subsequent change was made and only some specifications were re-tested, please explain what test reports have superseded and should be reviewed for each relevant specification.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">Incomplete - need to add documents in F6</span></p><p><span style="background-color: rgb(254,222,200);">Documents in F3 need translating to English and moving to F6 where not related to calibration and cross referencing to design requirements.</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="175"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="176"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.5.2 Design requirements</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p><strong> </strong>Provide the documented design requirements for the device.</p></td><td class="confluenceTd"><p> <a href="OV-C3.1.-Requirements-Specification_3342597.html" data-linked-resource-id="3342597" data-linked-resource-version="76" data-linked-resource-type="page">OV C3.1. Requirements Specification</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="177"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="178"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.5.3 Verification and validation plan</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>Provide an overall plan for design verification and validation, if applicable.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="179"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="180"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.5.4 Verification protocols and results</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>Test reports should document objectives, acceptance criteria, materials &amp; methods, results, protocol deviations, and conclusions.</p><p>If test results are considered representative for a group of devices (i.e. worst- case devices or comparative devices), then a justification for leveraging protocol(s) and report(s) should be provided.</p><p>Similarly, if testing has been undertaken on prototypes, previous generations of a device, or devices that otherwise do not represent the finished goods, a justification for the adequacy of this testing should be provided.</p><p>If multiple design verification / validation studies were conducted, please provide a flow chart or table that shows how the studies were conducted and highlight which study ultimately demonstrates that the design meets the product performance specifications.</p><p>For line extensions or devices based on “existing” devices, it may be possible to leverage data from testing undertaken on the existing devices. In this case, a rationale for the use of existing data must be provided, including:</p><p>·     Evidence of equivalence to the comparative devices – a table showing the similarities and differences greatly speeds the review process. Key things to consider include (but may not be limited to):</p><ul><li><p>Materials of construction</p></li><li><p>Indications for use</p></li><li><p>Methods of manufacturing</p></li><li><p>Key design features</p></li></ul><p>·     An evaluation of the impact of any differences on clinical safety, performance, and testing undertaken. The evaluation should support the conclusion that the new devices do not represent a worst case in terms of testing as compared to the devices tested.</p></td><td class="confluenceTd"><p> <span style="background-color: rgb(254,222,200);">?</span></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="181"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="182"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.5.5 Validation protocols and results</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>Please provide the protocols and results for design validation studies. See also 6.5.4 for guidance on appropriate contents and rationales.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="183"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="184"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.5.6 Usability study protocols and results</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>Please provide the protocols and results for usability studies. See also 6.5.4 for guidance on appropriate contents and rationales.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="185"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="186"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.5.7 Evidence to support the device lifetime in use</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>The lifetime of the device should be defined and considered relative to other parts of the dossier (e.g. risk management, clinical evaluation, PMS).</p><p>Product lifetime is normally considered as the time from first use until the device ceases to fulfil its intended use. This is not the same as “Shelf Life”.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="187"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="188"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.5.8 Sample Size Procedures</p></td><td class="confluenceTd"><p>Annex II, Section 6.1</p></td><td class="confluenceTd"><p>Clearly define how sample sizes have been determined and the rationale/ justification for the sample sizes. If the rationale is documented in a procedure provide the relevant procedure.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="189"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="190"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.11 Devices containing CMR or endocrine-disrupting substances referred to in GSPR 10.4.1 of Annex I of MDR</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.11.1 Data related to the estimation of potential patient or user exposure to the substances</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.d</p></td><td rowspan="4" class="confluenceTd"><p>GSPRs 10.4.1 - 10.4.5 describe specific requirements for devices that contain substances which are carcinogenic, mutagenic or toxic to reproduction and substances having endocrine-disrupting properties. Information and/or test data related to these requirements should be included in the Technical Documentation. This information may be provided either as a stand-alone section or incorporated into other relevant sections such as biocompatibility, labelling etc.</p><p>If evidence is based on published literature, manufacturers should rationalise the applicability of such literature data to their own device considering the nature of their device, intended purpose, contact with various body tissues and other substances etc.</p></td><td class="confluenceTd"><p> <a data-card-appearance="inline" href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/3342804/OV+F1.+Biocompatibility?atlOrigin=eyJpIjoiYWUyOTM2ZWU1NDIyNGEyNmE0Y2E0NTQ3MTc3ZGZjZjgiLCJwIjoiYyJ9" rel="nofollow">https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/3342804/OV+F1.+Biocompatibility?atlOrigin=eyJpIjoiYWUyOTM2ZWU1NDIyNGEyNmE0Y2E0NTQ3MTc3ZGZjZjgiLCJwIjoiYyJ9</a> </p></td><td rowspan="4" class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="191"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="192"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.11.2 Information/data on analysis of possible alternative substances, materials or designs</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.d</p></td><td class="confluenceTd"><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>6.11.3 Rationale for the presence of CMR and/or endocrine-disrupting substances above 0.1% (w/w) considering the alternatives</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.d</p></td><td class="confluenceTd"><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>6.11.4 Labelling indicating the presence of CMR and/or endocrine-disrupting substances above 0.1% (w/w)</p></td><td class="confluenceTd"><p>Annex II, Section 2</p></td><td class="confluenceTd"><p><strong>Not applicable</strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.12 Packaging and Transport Testing</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.12.1 Packaging drawings and/or configurations</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.a / e</p></td><td class="confluenceTd"><p>A complete packaging BoM and diagrams should be provided to illustrate how each device is packaged.</p></td><td class="confluenceTd"><p> <a href="3342987.html" data-linked-resource-id="3342987" data-linked-resource-version="20" data-linked-resource-type="page">OV F10.100 Product Release - Validation &amp; Verification</a> </p><p><a href="OV-C3.5.-Final-Product-Input%2C-Packaging-and-Release-Actions_202145793.html" data-linked-resource-id="202145793" data-linked-resource-version="20" data-linked-resource-type="page">OV C3.5. Final Product Input, Packaging and Release Actions</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="193"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="194"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.12.2 Packaging validation protocols</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.a / e</p></td><td rowspan="2" class="confluenceTd"><p>Please provide the protocols and reports for packaging validation. For sterile devices, this must include the validations carried out towards establishing the sterile barrier. For non-sterile devices, evidence should be provided to establish that the packaging sufficiently protects the device in order to enable it to achieve its intended performance.</p><p>·     Packaging testing needs to be undertaken in accordance with relevant standards. If such standards are not used, alternate methods must be duly justified in terms of their suitability and state of the art.</p><p>·     If all packaging configurations / device combinations have not been tested, a rationale based on worst case (i.e. heaviest and lightest devices, sharp or pointy edges, etc.) should be provided.</p><p>·     Changes to packaging could potentially be considered as significant changes. For Class III devices and Class IIb implantable devices, these must be reported to BSI for review and certificate re-issue.</p></td><td class="confluenceTd"><p> <a href="3342987.html" data-linked-resource-id="3342987" data-linked-resource-version="20" data-linked-resource-type="page">OV F10.100 Product Release - Validation &amp; Verification</a> </p><p><a href="OV-C3.5.-Final-Product-Input%2C-Packaging-and-Release-Actions_202145793.html" data-linked-resource-id="202145793" data-linked-resource-version="20" data-linked-resource-type="page">OV C3.5. Final Product Input, Packaging and Release Actions</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="195"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="196"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.12.3 Packaging validation reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.a / e</p></td><td class="confluenceTd"><p><a href="3342987.html" data-linked-resource-id="3342987" data-linked-resource-version="20" data-linked-resource-type="page">OV F10.100 Product Release - Validation &amp; Verification</a> </p><p><a href="OV-C3.5.-Final-Product-Input%2C-Packaging-and-Release-Actions_202145793.html" data-linked-resource-id="202145793" data-linked-resource-version="20" data-linked-resource-type="page">OV C3.5. Final Product Input, Packaging and Release Actions</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="197"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="198"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.12.4 Transit/transport testing protocols</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.a / e</p></td><td rowspan="2" class="confluenceTd"><p>Provide protocols and reports for any transit/transportation testing conducted on the device to establish transit endurance and maintenance of the sterile barrier in case of sterile devices.</p></td><td class="confluenceTd"><p> <a href="3342987.html" data-linked-resource-id="3342987" data-linked-resource-version="20" data-linked-resource-type="page">OV F10.100 Product Release - Validation &amp; Verification</a>  </p><p><a href="OV-C3.5.-Final-Product-Input%2C-Packaging-and-Release-Actions_202145793.html" data-linked-resource-id="202145793" data-linked-resource-version="20" data-linked-resource-type="page">OV C3.5. Final Product Input, Packaging and Release Actions</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="199"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="200"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.12.5 Transit/transport testing reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.a / e</p></td><td class="confluenceTd"><p> <a href="3342987.html" data-linked-resource-id="3342987" data-linked-resource-version="20" data-linked-resource-type="page">OV F10.100 Product Release - Validation &amp; Verification</a> </p><p><a href="OV-C3.5.-Final-Product-Input%2C-Packaging-and-Release-Actions_202145793.html" data-linked-resource-id="202145793" data-linked-resource-version="20" data-linked-resource-type="page">OV C3.5. Final Product Input, Packaging and Release Actions</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="201"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="202"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.15 Devices with a measuring or diagnostic function</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.15.1 Protocols for tests associated with establishing the device limits of accuracy, precision, calibration</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.f</p></td><td rowspan="2" class="confluenceTd"><p>If the device has a measuring function or diagnostic function, include test protocols and reports used for verifying or establishing the device limits of accuracy, precision, calibration etc</p><p>Refer to MEDDEV 2.1/5 for guidance on criteria that qualify a device as having a measuring function.</p><p><a class="external-link" href="https://ec.europa.eu/docsroom/documents/10283/attachments/1/translations" rel="nofollow">MEDDEV 2. 1/5 MEDICAL DEVICES WITH A MEASURING FUNCTION</a> </p></td><td class="confluenceTd"><p><a href="OV-F7.-Calibration_3342832.html" data-linked-resource-id="3342832" data-linked-resource-version="10" data-linked-resource-type="page">OV F7. Calibration</a> </p><p><a href="OV-F7.1-Heart-Rate-Calibration_76349441.html" data-linked-resource-id="76349441" data-linked-resource-version="20" data-linked-resource-type="page">OV F7.1 Heart Rate Calibration</a> </p><p><a href="OV-F7.2-Oxygen-Saturation-Calibration-on-an-Hypobaric-Chamber_78577665.html" data-linked-resource-id="78577665" data-linked-resource-version="15" data-linked-resource-type="page">OV F7.2 Oxygen Saturation Calibration on an Hypobaric Chamber</a> </p><p><a href="OV-F7.3-Arterial-Blood-Pressure-Calibration_76972033.html" data-linked-resource-id="76972033" data-linked-resource-version="23" data-linked-resource-type="page">OV F7.3 Arterial Blood Pressure Calibration</a> </p><p><a href="OV-F7.4-Skin-Detection-Calibration_52756481.html" data-linked-resource-id="52756481" data-linked-resource-version="12" data-linked-resource-type="page">OV F7.4 Skin Detection Calibration</a> </p><p><a href="OV-F7.5-Temperature-sensor-calibration_131268609.html" data-linked-resource-id="131268609" data-linked-resource-version="6" data-linked-resource-type="page">OV F7.5 Temperature sensor calibration</a> </p><p><a href="153354241.html" data-linked-resource-id="153354241" data-linked-resource-version="7" data-linked-resource-type="page">OV F7.6 Signal Quality Assesment (SQA) calibration</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="203"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="204"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.15.2 Reports for tests associated with establishing the device limits of accuracy, precision, calibration</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.f</p></td><td class="confluenceTd"><p><a href="OV-F7.-Calibration_3342832.html" data-linked-resource-id="3342832" data-linked-resource-version="10" data-linked-resource-type="page">OV F7. Calibration</a> </p><p><a href="OV-F7.1-Heart-Rate-Calibration_76349441.html" data-linked-resource-id="76349441" data-linked-resource-version="20" data-linked-resource-type="page">OV F7.1 Heart Rate Calibration</a> </p><p><a href="OV-F7.2-Oxygen-Saturation-Calibration-on-an-Hypobaric-Chamber_78577665.html" data-linked-resource-id="78577665" data-linked-resource-version="15" data-linked-resource-type="page">OV F7.2 Oxygen Saturation Calibration on an Hypobaric Chamber</a> </p><p><a href="OV-F7.3-Arterial-Blood-Pressure-Calibration_76972033.html" data-linked-resource-id="76972033" data-linked-resource-version="23" data-linked-resource-type="page">OV F7.3 Arterial Blood Pressure Calibration</a> </p><p><a href="OV-F7.4-Skin-Detection-Calibration_52756481.html" data-linked-resource-id="52756481" data-linked-resource-version="12" data-linked-resource-type="page">OV F7.4 Skin Detection Calibration</a> </p><p><a href="OV-F7.5-Temperature-sensor-calibration_131268609.html" data-linked-resource-id="131268609" data-linked-resource-version="6" data-linked-resource-type="page">OV F7.5 Temperature sensor calibration</a> </p><p><a href="153354241.html" data-linked-resource-id="153354241" data-linked-resource-version="7" data-linked-resource-type="page">OV F7.6 Signal Quality Assesment (SQA) calibration</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="205"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="206"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse"> 6.16 Devices intended to be connected to other devices to operate as intended</span></strong></p></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.16.1 Protocols for tests associated with establishing the safety and performance of the device and the combination while connected to other devices and their interoperability</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.g</p></td><td rowspan="2" class="confluenceTd"><p>If the device is intended to be connected to other devices to operate as intended, include test protocols and reports that establish the safety and performance of the combination of devices including addressing their interoperability and any usability elements.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="207"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="208"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>6.16.2 Reports for tests associated with establishing the safety and performance of device and the combination while connected to other devices and their interoperability</p></td><td class="confluenceTd"><p>Annex II, Section 6.2.g</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="209"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="210"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr></tbody></table></div><p> </p><p><strong>Part G: Clinical Evaluation, PMS and PMCF</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="9e02af2a-4af3-447e-9e6d-9dfcdc6844ce" class="confluenceTable"><colgroup><col style="width: 358.0px;"/><col style="width: 290.0px;"/><col style="width: 395.0px;"/><col style="width: 532.0px;"/><col style="width: 222.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.6 Clinical Evaluation</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.6.1 Clinical development strategy</p></td><td class="confluenceTd"><p>Annex XIV, Section 1.a</p></td><td class="confluenceTd"><p>Explain the clinical development strategy for the device.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/ee7ee8eb-841a-4085-a8dc-af6d55ebf1bd_en?filename=mdcg_2024-5_en.pdf" rel="nofollow">MDCG 2024-5 guidance on content of the Investigator’s Brochure for clinical investigations of medical devices</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/690de85a-ac17-45ea-bb32-7839540c25c4_en?filename=mdcg_2024-3_en_0.pdf" rel="nofollow">MDCG 2024-3 Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devices</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/1b5f9cc0-cea0-4459-921f-eaf4b4f80983_en?filename=mdcg_2023-7_en.pdf" rel="nofollow">MDCG 2023-7 Practical application of Articla 61(4)-(6) sufficient level of access</a></p><p><a class="external-link" href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52023XC0508(01)" rel="nofollow">EUR-Lex - 52023XC0508(01) - EN - EUR-Lex</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/ba8069a1-6881-4360-b52b-6cab048aee43_en?filename=mdcg_2021-28_en.pdf" rel="nofollow">MDCG 2021-28 Substantial modification of clinical investigation under Medical Device Regulation</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/54d417c4-df69-416f-a2bd-7a5de8cba611_en?filename=mdcg_2021-20_en.pdf" rel="nofollow">MDCG 2021-20 Instructions for generating CIV-ID for MDR Clinical Investigations</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/13265ec7-1776-41af-afb6-e0a64bc407b5_en?filename=mdcg_2021-8_en.pdf" rel="nofollow">MDCG 2021-08 Clinical investigation application/notification documents</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/f124f630-389e-4c45-90dc-24ec0a707838_en?filename=mdcg_2021-6_en.pdf" rel="nofollow">MDCG 2021-6 rev.1</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/0537d335-7eed-4087-b65d-3c2bd8c72c1a_en?filename=md_mdcg_2020-10-1_guidance_safety_reporting_en.pdf" rel="nofollow">MDCG 2020-10/1 Rev 1 Safety reporting in clinical investigations of medical devices under the Regulation (EU) 2017/745</a></p></td><td class="confluenceTd"><p><a href="OV-G1.1.-Clinical-Evaluation-Plan_3343029.html" data-linked-resource-id="3343029" data-linked-resource-version="78" data-linked-resource-type="page">OV G1.1. Clinical Evaluation Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="211"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="212"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.6.2 Clinical development plan</p></td><td class="confluenceTd"><p>Annex XIV, Section 1.a</p></td><td class="confluenceTd"><p>See MDR Annex XIV, Part A, 1 (a) final indent.</p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-191010-mdce-n55.pdf" rel="nofollow">IMDRF MDCE WG/N55 FINAL:2019 (formerly GHTF/SG5/N1R8:2007) Clinical Evidence - Key Definitions and Concepts</a></p></td><td class="confluenceTd"><p><a href="OV-G1.1.-Clinical-Evaluation-Plan_3343029.html" data-linked-resource-id="3343029" data-linked-resource-version="78" data-linked-resource-type="page">OV G1.1. Clinical Evaluation Plan</a>  </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="213"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="214"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.6.3 Clinical evaluation plan</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.c</p><p>Annex XIV, Section 1.a</p></td><td class="confluenceTd"><p>Please provide the clinical evaluation plan documented and used for the device.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/a6d29444-b5d5-4afb-8024-10be85256aa7_en?filename=md_mdcg_2020_6_guidance_sufficient_clinical_evidence_en.pdf" rel="nofollow">MDCG 2020-6 Regulation (EU) 2017/745: Clinical evidence needed for medical devices previously CE marked under Directives 93/42/EEC or 90/385/EEC A guide for manufacturers and notified bodies</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/575a0f79-e3a0-4a96-9ce0-930576c12aa2_en?filename=md_mdcg_2020_5_guidance_clinical_evaluation_equivalence_en.pdf" rel="nofollow">MDCG 2020-5 Clinical Evaluation - Equivalence A guide for manufacturers and notified bodies</a></p></td><td class="confluenceTd"><p><a href="OV-G1.1.-Clinical-Evaluation-Plan_3343029.html" data-linked-resource-id="3343029" data-linked-resource-version="78" data-linked-resource-type="page">OV G1.1. Clinical Evaluation Plan</a>  </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="215"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="216"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.6.4 Clinical evaluation report</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.c</p><p>Annex XIV, Section 4</p></td><td class="confluenceTd"><p>Clinical evaluations are required for all medical devices.</p><p>Representative clinical data must be provided for all indications and variants. Justifications for why one group of data is representative of another must be clearly substantiated.</p><p>If no clinical investigation data are available for the subject device and the Clinical Evaluation relies on a justification of equivalence of comparative devices, the justification must identify and discuss the potential clinical impact of all differences between the subject and comparable devices relative to intended use, technical, or biological factors (MDR Annex XIV Sec. 3). In the context of equivalence, Manufacturers should also include any additional information necessary to show compliance with the requirements of MDR Article 61.5 for implantable devices and Class III devices.</p><p>If the device is a system with multiple components, the clinical evaluation must consider all the components of the device. Similarly, the clinical evaluation must give due consideration to the accessories associated with the device.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/02f50abc-91db-4ad9-b137-6ffedb690716_en?filename=md_2020-13-cea-report-template_en.pdf" rel="nofollow">MDCG 2020-13 Clinical evaluation assessment report template</a></p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/19d9e24f-2808-4e00-bfeb-75892047407d_en?filename=md_mdcg_2020_1_guidance_clinic_eva_md_software_en.pdf" rel="nofollow">MDCG 2020-1 Guidance on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-191010-mdce-n56.pdf" rel="nofollow">IMDRF MDCE WG/N56FINAL:2019 (formerly GHTF/SG5/N2R8:2007) Clinical Evaluation</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-170921-samd-n41-clinical-evaluation_1.pdf" rel="nofollow">IMDRF/SaMD WG/N41FINAL:2017 Final Document: Software as a Medical Device (SaMD): Clinical Evaluation</a></p></td><td class="confluenceTd"><p><a href="OV-G1.2.1-Clinical-Evaluation-Report-ONAVITAL-Prototype_49446913.html" data-linked-resource-id="49446913" data-linked-resource-version="12" data-linked-resource-type="page">OV G1.2.1 Clinical Evaluation Report ONAVITAL Prototype</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="217"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="218"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.6.5 CVs of the relevant personnel associated with the Clinical evaluation report to establish appropriate competence</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.c</p></td><td class="confluenceTd"><p><strong> </strong>A justification should be provided (with appropriate evidence) to substantiate the qualifications of individual(s) conducting / approving the clinical evaluation.</p></td><td class="confluenceTd"><p> <a href="OV-G1.1.-Clinical-Evaluation-Plan_3343029.html" data-linked-resource-id="3343029" data-linked-resource-version="78" data-linked-resource-type="page">OV G1.1. Clinical Evaluation Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="219"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="220"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.6.6 Clinical investigation protocols</p></td><td class="confluenceTd"><p>Annex XV</p></td><td class="confluenceTd"><p>For devices without suitable equivalents and / or insufficient data in the literature, pre-market clinical investigation may be required.</p><p>In addition, for Class III devices and Class IIb implantable devices, pre- market clinical investigation will be required unless:</p><p>·     The device is demonstrated to be equivalent to another of the manufacturer’s own devices with sufficient clinical data available demonstrating conformity with the relevant GSPRs</p><p>·     The device is demonstrated to be equivalent to an already marketed device of another manufacturer and a contract is in place explicitly allowing ongoing access to that manufacturer’s Technical Documentation</p><p>·     For listed device types where the clinical evaluation is based on sufficient data and in compliance with relevant CS</p><p>·     The device had been lawfully placed on the market or put into service per Directives 90/385/EEC or 93/42/EEC, where the clinical evaluation is based on sufficient clinical data and is in compliance with any relevant CS;</p><p>·     Annex XIV and XV describe Clinical Evaluation and Clinical Investigations, respectively. Guidance is also available in EN-ISO 14155 Clinical investigation of medical devices for human subjects - Good clinical practice</p><p>If a pre-market clinical investigation has been conducted, please ensure:</p><p>·     appropriate documentation (CIP, letter of “no objection” from the Competent Authority, evidence of Ethics approval, final report, etc.) is provided;</p><p>·     the final clinical trial protocol agrees with that submitted to the Competent Authority, and evidence that any deviations have been agreed with the CA has been provided;</p><p>·     the final report demonstrates that requirements for all safety and performance endpoints have been met;</p><p>·     there are no open clinical investigations relevant to your devices with endpoints related to safety or performance claims.</p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-191010-mdce-n57.pdf" rel="nofollow">IMDRF MDCE WG/N57FINAL:2019 (formerly GHTF/SG5/N3:2010) Clinical Investigation</a></p></td><td class="confluenceTd"><p><a href="OV-G1.2.1-Clinical-Evaluation-Report-ONAVITAL-Prototype_49446913.html" data-linked-resource-id="49446913" data-linked-resource-version="12" data-linked-resource-type="page">OV G1.2.1 Clinical Evaluation Report ONAVITAL Prototype</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="221"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="222"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.6.7 Clinical investigation results</p></td><td class="confluenceTd"><p>Annex XV</p></td><td class="confluenceTd"><p>If a pre-market clinical investigation has been conducted, please ensure:</p><p>·     the final report demonstrates that requirements for all safety and performance endpoints have been met;</p><p>·     there are no open clinical investigations relevant to your devices with endpoints related to safety or performance claims.</p><p><strong> </strong>See also 6.6.6</p><p><a class="external-link" data-card-appearance="inline" href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52023XC0508(01)" rel="nofollow">https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52023XC0508(01)</a> </p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="223"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="224"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.6.8 Statistical analysis plans</p></td><td class="confluenceTd"><p>Annex XIV, Section 1</p></td><td class="confluenceTd"><p><strong> </strong>A clear description must be provided of the statistical tools, techniques,</p><p>analyses used in the design and conduct of clinical investigations, and analysis of clinical data within the overall clinical evaluation.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="225"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="226"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.6.9 Copies of literature articles</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.c</p><p>Annex XIV, Section 1</p></td><td class="confluenceTd"><p>A copy of all literature articles selected and analysed within the clinical evaluation report should be included in the Technical Documentation.</p></td><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="227"><span class="placeholder-inline-tasks">Complete</span></li><li class="checked" data-inline-task-id="228"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p><strong> </strong>6.6.10 Summary of Safety and Clinical Performance</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.c</p></td><td class="confluenceTd"><p>For Class III and implantable devices other than custom-made or investigational devices, a Summary of Safety &amp; Clinical Performance (SSCP) per Article 32 must be provided in the Technical Documentation.</p><p>·     The SSCP should be written clearly and understandable to the intended user and patient (if relevant) and should contain all the elements listed in MDR Article 32, Sec 2.</p><p>·     Please consult current available guidance for SSCP content and format as per MDCG 2019-9.</p><p>·     A draft SSCP in English is acceptable at the time of initial submission.</p><p>·     Once the SSCP has been finalised based on BSI review, Manufacturers should submit the final version of the English SSCP, which is in pdf format and is printable, searchable before a certificate recommendation can be made.</p><p>·     The SSCP should be updated annually (as per Article 61), if indicated, over the lifetime of the device as needed, and updates should be defined in the Post-Market Surveillance Plan.</p><p>For Class IIa implantable and Class IIb implantable WET (Well-Established Technologies) devices, MDR allows NBs to choose representative devices from each device category or generic device group respectively for the assessment of Technical Documentation. The SSCPs for such devices chosen as the representative samples will be validated by the NB as part of the Technical Documentation assessment for those devices. The MDCG document 2019-9 requires that NBs also upload the <u>unvalidated</u> SSCPs of the devices that were not chosen as representative devices (but are part of the same device categories or generic device groups) to EUDAMED. Hence Manufacturers may submit these unvalidated SSCPs at any time during the certification process to BSI, but before a BSI Scheme Manager prepares and makes a recommendation for certification based on the completion of all the required conformity assessments (including Technical Documentation assessment) for the relevant device categories or generic device groups.</p><p>(The MDCG guidance on SSCPs, MDCG 2019-9, also includes several requirements related to languages, translations of SSCPs depending on the Member State requirements related to languages and the availability of translated SSCPs on EUDAMED prior to placing affected devices on the market within these Member States. Manufacturer’s processes/procedures related to making the translated SSCPs available to BSI (for the NB to upload these to EUDAMED) and ensuring that they are available on EUDAMED prior to placing the devices on the market within these Member States will be audited as part of the BSI QMS audits)</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/5f082b2f-8d51-495c-9ab9-985a9f39ece4_en?filename=md_mdcg_2019_9_sscp_en.pdf" rel="nofollow">MDCG 2019-9 Rev.1 Summary of safety and clinical performance A guide for manufacturers and notified bodies</a></p></td><td class="confluenceTd"><p><a href="OV-G1.3-Summary-of-Safety-and-Clinical-Performance-ONAVITAL_80117761.html" data-linked-resource-id="80117761" data-linked-resource-version="12" data-linked-resource-type="page">OV G1.3 Summary of Safety and Clinical Performance ONAVITAL</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="229"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="230"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.7 Post-market surveillance</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.7.1 Post Market Surveillance data (Market History, worldwide and EU sales volumes, Complaints data and trend analyses; Vigilance data and trend analyses; data from other PMS sources)</p></td><td class="confluenceTd"><p>Annex III, Section 1.1</p></td><td class="confluenceTd"><p>Please provide sales, complaints and vigilance data for the last 5 years for your device,</p><p>·     Sales and complaints data should include sales outside of the EU. A breakdown should be provided to enable evaluation of sales and complaints by region.</p><p>·     Complaints data should be evaluated rather than just listed. For example, why is the complaints rate considered acceptable? Have any trends been analysed and noted, or corrective actions taken? What is the status of these actions? Has a comparison of PMS data been made to the expected occurrence in the risk assessment? Full details of vigilance issues should be provided, including the status of any Field Safety Corrective Actions or Notices, the associated CAPAs and patient outcomes. This data should include FSCA or FSN outside the EU, if related to a device which is sold in the EU.</p><p>·     Ensure that the PMS data submitted at the time of the submission is up to date.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/af1433fd-ed64-4c53-abc7-612a7f16f976_en?filename=mdcg_2023-3_en_0.pdf" rel="nofollow">MDCG 2023-3 Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices</a></p></td><td class="confluenceTd"><p><a href="OV-G2.1.-Post-Market-Surveillance-Plan_3343062.html" data-linked-resource-id="3343062" data-linked-resource-version="11" data-linked-resource-type="page">OV G2.1. Post-Market Surveillance Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="231"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="232"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.7.2 Post market surveillance plan</p></td><td class="confluenceTd"><p>Annex III, Section 1.1</p></td><td class="confluenceTd"><p>A Post-Market Surveillance Plan (PMS Plan) commensurate with the product risk, lifetime, and available clinical data should be provided for each device / device family.</p><p>·     Ensure that the PMS plan adequately justifies the monitoring of the safety and intended performance of the device.</p><p>·     If Post-Market Clinical Follow-up (PMCF) is not part of the PMS Plan, please ensure that adequate justification is provided, based on the risk and clinical data available for the device.</p><p>·     A copy of the Post Market Surveillance procedure should also be provided. Please note that the procedure is not the same as the Plan – the former refers to the manufacturer’s quality system requirements and is generic to all devices marketed by a manufacturer, whereas the latter is specific to the subject device, and can only be generated in light of data from the clinical evaluation and risk evaluation for that device.</p></td><td class="confluenceTd"><p> <a href="OV-G2.1.-Post-Market-Surveillance-Plan_3343062.html" data-linked-resource-id="3343062" data-linked-resource-version="11" data-linked-resource-type="page">OV G2.1. Post-Market Surveillance Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="233"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="234"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.7.3 Periodic Safety Update Reports (if available)</p></td><td class="confluenceTd"><p>Annex III, Section 1.2</p></td><td class="confluenceTd"><p>For Class III, IIb, and IIa devices, manufacturers must prepare a periodic safety update report (“PSUR”) for each device or group of devices summarising results and conclusions of post-market surveillance data analysis as a result of the PMS plan described above. The PSUR should contain all the elements outlined in MDR Article 86 and any applicable MDCG guidance documents. Any PSURs the manufacturers may have</p><p>issued by the time of submission must be included.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/a7df24c3-d4a3-4218-a8e0-726febfa01c2_en?filename=mdcg_2022-21_en.pdf" rel="nofollow">MDCG 2022-21 GUIDANCE ON PERIODIC SAFETY UPDATE REPORT (PSUR) ACCORDING TO REGULATION (EU) 2017/745 (MDR)</a></p></td><td class="confluenceTd"><p>Device not placed on the market yet</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="235"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="236"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr><tr><td class="confluenceTd"><p>6.7.4 Post market clinical follow-up plan &amp; protocols</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.d</p><p>Annex XIV, Section 6</p></td><td class="confluenceTd"><p>Please provide a PMCF plan including all necessary elements outlined per Part B of MDR Annex XIV and any applicable MDCG guidance documents.</p><p>If the PMCF plan includes a PMCF study, include the study protocol.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/a5cdb303-c782-4010-8723-7d389af678f7_en?filename=md_mdcg_2020_7_guidance_pmcf_plan_template_en.pdf" rel="nofollow">MDCG 2020-7 Post-market clinical follow-up (PMCF) Plan Template A guide for manufacturers and notified bodies</a></p><p><a class="external-link" href="https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-210325-wng65.pdf" rel="nofollow">IMDRF MDCE WG/N65FINAL:2021 Post-Market Clinical Follow-Up Studies</a></p></td><td class="confluenceTd"><p><a href="OV-G2.2.-Post-Market-Clinical-Follow-Up-Plan_80150529.html" data-linked-resource-id="80150529" data-linked-resource-version="9" data-linked-resource-type="page">OV G2.2. Post-Market Clinical Follow Up Plan</a> </p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="237"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="238"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr><tr><td class="confluenceTd"><p>6.7.5 Post market clinical follow-up reports</p></td><td class="confluenceTd"><p>Annex II, Section 6.1.d</p><p>Annex XIV, Section 7</p></td><td class="confluenceTd"><p>Include any information and reports from PMCF activities previously carried out.</p><p>This should clearly identify the PMCF study, which products are included and the applicable indication of use. In cases with multiple products and studies a table is preferable.</p><p>The Notified Body may be required to periodically review results from</p><p>ongoing or completed PMCF studies following CE mark certification, including a specialised clinical evaluator in some cases.</p><p><a class="external-link" href="https://health.ec.europa.eu/document/download/11121036-696a-4589-a311-c5525bd84df3_en?filename=md_mdcg_2020_8_guidance_pmcf_evaluation_report_en.pdf" rel="nofollow">MDCG 2020-8 Post-market clinical follow-up (PMCF) Evaluation Report Template A guide for manufacturers and notified bodies</a></p></td><td class="confluenceTd"><p>Device not placed on the market yet</p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li data-inline-task-id="239"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="240"><span class="placeholder-inline-tasks">Incomplete</span></li></ul><p><strong>Not Applicable</strong></p></td></tr></tbody></table></div><p /><p><strong>Part J: Declaration of Conformity</strong></p><div class="table-wrap"><table data-table-width="1800" data-layout="wide" data-local-id="ed8fc7af-c1dc-4abd-bdea-de06d7e884bb" class="confluenceTable"><colgroup><col style="width: 358.0px;"/><col style="width: 295.0px;"/><col style="width: 470.0px;"/><col style="width: 315.0px;"/><col style="width: 360.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Section Title / Item</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">EU MDR Cross References</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Additional Guidance</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Link to Medical Device File document</span></strong></p></td><td data-highlight-colour="#4c9aff" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">Completeness</span></strong></p></td></tr><tr><td data-highlight-colour="#4c9aff" colspan="5" class="confluenceTd"><p><strong><span class="legacy-color-text-inverse">6.18 Declaration of Conformity</span></strong></p></td></tr><tr><td class="confluenceTd"><p>6.18.1 Draft Declaration of conformity provided as per Annex IV of MDR</p></td><td class="confluenceTd"><p>Annex IV</p></td><td class="confluenceTd"><p><strong> </strong>The EU Declaration of Conformity should include all the information listed in MDR Annex IV.</p></td><td class="confluenceTd"><p> <a href="3343086.html" data-linked-resource-id="3343086" data-linked-resource-version="9" data-linked-resource-type="page">OV Part J: Declaration of Conformity - ONALABS QMS - Confluence</a></p></td><td class="confluenceTd"><ul class="inline-task-list" data-inline-tasks-content-id="3342348"><li class="checked" data-inline-task-id="241"><span class="placeholder-inline-tasks">Complete</span></li><li data-inline-task-id="242"><span class="placeholder-inline-tasks">Incomplete</span></li></ul></td></tr></tbody></table></div><p><strong> </strong></p><h3 id="OVONAVITALMedicalDeviceFileChecklist-4.DocumentDistribution">4. Document Distribution</h3><div class="table-wrap"><table data-table-width="760" data-layout="default" data-local-id="e5988672-ffc0-4732-9daf-ca0c38be5c42" class="confluenceTable"><colgroup><col style="width: 340.0px;"/><col style="width: 340.0px;"/></colgroup><tbody><tr><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><p>Action/ information</p></td></tr><tr><td class="confluenceTd"><p>This document is intended for an internal and (restricted) external audience.</p><p>All external distribution of this document must be approved prior to circulation.</p></td><td class="confluenceTd"><p>Information</p><p> </p></td></tr></tbody></table></div><p> </p><p />
                    </div>

                    
                                                      
                </div>             </div> 
            <div id="footer" role="contentinfo">
                <section class="footer-body">
                    <p>Document generated by Confluence on Jun 30, 2025 15:42</p>
                    <div id="footer-logo"><a href="http://www.atlassian.com/">Atlassian</a></div>
                </section>
            </div>
        </div>     </body>
</html>
